Professional Documents
Culture Documents
11 94
11 94
RE/PIRATORy
A MONTHLY SCIENCE JOURNAL
39TH YEAR— ESTABLISHED 1956
Nathan Coos
Leslie Speaks !
d
Bronchopulmonary Dysplasia
005 007
l5niml.D./23mmO.D !5mmI.D./22rnmOD
Low profile and white in Tapered (ISO dimensions and
color for tracheostomized testing) to allow standard
individuals connection with disposable
May he used in-line with ventilator tubing and adapters
flexible rubber tubing Aqua color is easier to see in-
line
4521 Campus Drive, Suite 273, Irvine, California 92715 (714) 833-8255
Outside CA: (800) 634-5397 FAX: (714) 833-8299
V/ir patients
are mastering
SMI tlierapy in
almost no time.
That's why 111
choose Coach®
every time.
Thanks, DHD."
Brenda Kalette, RRT
With the
DHD Coach
incentive
spirometer,
accurate SMI
^ therapy is
" 'simplified
1'800'847'8000
Visit AARC Booths 611,
613 and 615 in Las Vegas
A
RE/PIRATORy C&RE
Monthly Science Joumal. Established 1956. Otiicial Journal of the American Association tor Respiratory Care
EDITORIAL OFFICE
Lane
11031) Atiles
Dallas TX
75229
CONTENTS November 1994
Volume 39, Number 11
1214)243-2272
EDITOR
Pal Brougtier BA RRT
MANAGING EDITOR 1047 Clinical Coinparison of Two Aerosol Holding Chambers: ACE vs
Ray Maslerrer BA RRT
Aerochamber
EDITORIAL BOARD by Robert J Perry, Edward G Lcmgenback, and Jonathan S
Dean Hess PhD RRT. Chairman
Thomas A Barnes EdD RRT llowite —Stonv Brook, New York
Richard D Branson RRT
Crystal L Dunievy EdD RRT
G Durbin Jr MD
Charles
Thomas D East PhD TEST YOUR RADIOLOGIC SKILL
Neil R Maclntyrc MD 1051 Airway Compromise in Two Patients with Aplastic Anemia and
Shelley C Mishoe PhD RRT
Joseph L Rau PhD RRT
Coagulation Abnormalities
James K Stoller MD by Loretta D Gleaton and Frederick P Ognibene—Bethesda,
CONSULTING EDITORS Maryland
Frank E Biondo BS RRT
Howard J Birenbaum MD
Robert L Chatbum RRT
Patricia Ann Doorley MS RRT
CORRECTIONS
Donald R Elton MD 1050 Errors in Two CPGs Published in August (Neonatal Time-
Robert R Pluck Jr MS RRT Triggered, Pressure-Limited, Time-Cycled Mechanical Ventilation
Ronald B George MD
James M Hurst MD (Respir Care 1994;39(8):812-816] and Application of Continuous
Charles G Irvin PhD
Positive Airway Pressure to Neonates via Nasal Prongs or
MS Jastremski MD
Robert M
Kacmarek PhD RRT Nasopharyngeal Tube [Respir Care 1994;39(8):817-823]
Hugh S Mathewson MD
Michael McPeck BS RRT
David J Pierson MD
John Shigeoka MD BOOKS, FILMS, TAPES, & SOFTWARE
Jack Wanger MBA RPFT RRT 1057 Lung Function: Assessment and Application in Medicine, 5th edi-
Jeffrey J Ward MEd RRT
tion, by JE Cotes
JOURNAL ASSOCIATES reviewed by Charles G Inin — Denver. Colorado
Stephen M Ayres MD
Reuben M Cliemiaek MD
Donald F Egan MD 1057 Snoring and Obstructive Sleep Apnea, 2nd edition, by David NF
Gareth B Gish MS RRT
George Gregorv' MD Fairbanks MD and Shiro Fujita MD
Ake Grenvik MD reviewed by Timothy R Chappell — Piano, Texas
H Fredenck Helmholz Jr MD
John E Hodgkin MD
William F Miller MD
Thomas L Petty MD LETTERS
Alan K Pierce MD
Henning Pontoppidan MD 1058 Enors in August CPGs
John
Barry
W
Severinghaus
A Shapiro MD
MD by Stephen M Picca —East Meadow, New York
PRODUCTION STAFF
Linda Barcus Donna Knauf
Steve Bowden Denise Ditzenberger
Respiratory Care (ISSN 0020-1324) is a monthly publication of Daedalus Enterprises tnc for the American Association for Respiratory Care. Copyright ® 1994 by Daedalus
Enterprises Inc. 1 1030 Abies Lane, Dallas TX 75229. All rights reserved. Reproduction in whole or in part without the express, written permission of Daedalus Enterprises Inc
is prohibited. The opinions expressed in any anicle or editorial are those of the author and do not necessarily reflect the views of Daedalus Enterprises Inc. the Editorial Board.
or the American Association for Respiratory Care. Neither can Daedalus Enterprises Inc. the Editorial Board, or the Amercian Association for Respiratory Care be responsible
for the consequences of the clinical applications of any methods or devices described herein. Printed in L'SA.
Respiratory Care is indexed in Hospital Literature Index and in Cumulative Index to Nursing and Allied Health Literature.
Subscription Rates; $5.00 per copy; $50.00 per year (12 issues) in the US; $70.00 in all other countries (add $84.00 for airmail).
Second Class Postage paid at Dallas, TX. POSTMASTER: Send address changes to Respiratory Care, Daedalus Enterprises, Inc, 1 1030 Abies Lane, Dallas TX 75229.
^^2.^9^
^^^.
^^'S'fi
4S-
"^^2:
^?^^
^ai</
>o7
\ahD^\MmKmmm
I-80()-74H-5i.S5 • 1-801-972-2455
Circle 116 on reader service card
1
MARKETING DIRECTOR
Dale Griffiths
ADVERTISING ASSISTANT
Beth Binkley
PRODUCT ADVERTISING:
RATES & MEDIA KITS
Jim Burke
Williams & Wilkins
428 E. Preston St.
Baltimore, MD
21202
(800)528-1843
fax (410) 528-4452
RECRUITMENT ADVERTISING:
Beth Binkley
Respiratory Care
1 1030 Abies Lane
Dallas TX 75229-4593
(214)243-2272
fax (214) 484-6010
Neonatal Sedation: More Art Than Science (commentary) — AR Wolf. Lancet 1994:344:628.
(Pertains to the paper by Jacqz-Aigrain et al abstracted on Page 1022.)
Evolution of Therapy for Cystic Fibrosis— PB Davis. N Engl J Med 1994:331( 10):672. (Pertains to
the paper by Fuchs et al abstracted on Page 1026.)
Multisite Evaluation of a Continuous 3.3 mm Hg, and at pHa values of 7.23-7.57. and the pharmacological effect of the terbu-
Intraarterial Blood Gas Monitoring average bias and precision were 0.01 ± 0.04. taline in the inhaler were measured by scores
System —CP Larson Jr, J Vender. A Seiver. Observed drift per day was — 1.2% for arterial for inhalation technique and clinical response.
Anesthesiology 1994;81(3):543. Po;. 0.3 mm Hg for arterial Pco;. and 0.01 for None of the 3-year-old children used the de-
pH. Bias and precision for samples compared vice efficiently, but 43% of the 4-year-old,
BACKGROUND: We compared the perfor- in two pairs of like-model in vitro blood gas 67% of the 5-year-old. and 80% of the 6-year-
mance of a new. continuous intraarterial blood analyzers were 0.4 ± 4.6% for arterial Pq; old children used the inhaler correctly.
gas (CIABG) monitor with arterial values ob- over the full range, and 0.4 ± 3.7 mm Hg for Although inhaler technique was not perfect in
tained periodically and analyzed by conven- values less than 100 mm Hg, -0.5 ± 1.8 mm the younger age group, 50% of the 3-year-old
tional equipment. METHODS: A CIABG Hg for arterial Pco;. and 0.01 ± 0.01 for pHa. children demonstrated clinical improvement of
monitoring system consisting of a sterile, dis- Although the occasional marked discrepancies asthma symptoms after inhalation. In the older
posable, fiberoptic sensor and a microproces- between one or inore CIABG and in vitro val- age groups, 79%, 92%, and 100% of the 4-, 5-,
sor-controlled monitor with a self-contained ues could sometimes be corrected by flushing and 6-year-old children demonstrated clinical
calibration unit and detachable display panel the arterial catheter or repositioning the sensor, symptoms after in-
improveiTient of asthma
was used. The sensor was inserted through a usually we could not determine the cause of the halation. It is new mode of
concluded that the
20-G radial artery cannula. Light was transmit- discrepancy or which values were the more ac- dry powder delivery system (Bricanyl
ted from the monitor to the sensor tip where it curate. CONCLUSIONS: Over the range of Turbuhaler) can be used in young asthmatic
reacted with fluorescent dyes sensitive to oxy- values and under the clinical conditions stud- children who are 4 years of age and above.
gen or hydrogen ions (analytes). The change in ied, CIABG monitoring provides immediate
the intensity of the photoluminescent radiation blood gas results and trend information with Placebo-Controlled Trial of Midazolam
caused by the analytes was measured every 20 sufficient agreement with in vitro results to be Sedation in Mechanically Ventilated
s and derived blood gas values were displayed. reliable for decision making in most clinical —
Newborn Babies E Jacqz-Aigrain. P Daoud.
Twenty-nine sensors were evaluated in 29 sur- circumstances. Generally, the differences in P Burtin, L Desplanques. F Beaufils. Lancet
gical or intensive care unit patients at one of the values between the two methods of analy- 1994:344:646.
three institutions (Stanford University sis were the result of the combination of the in-
Hospital, Evanston Memorial Hospital, and the herent errors of each method. Additional stud- Although midazolam is used for .sedation of
Palo Alto Veterans .Administration Hospital). ies need to be undertaken to evaluate the per- mechanically ventilated newborn babies, this
The duration of study averaged 6 h (5-8 h) in formance of the CIABG monitor across wider treatment has not been evaluated in a ran-
the operating room, and 46 h (7-121 h) in the ranges of blood gas values, especially for arte- doiTiised trial. We have done a prospective
intensive care unit. A total of 552 values were rial Po; values less than 60 mm Hg and arterial placebo-controlled study of the effects of mi-
compared with those obtained at regular inter- Pco; values greater than 50 mm Hg. dazolam on haemodynamic variables and seda-
vals and analyzed in the hospital blood gas lab- tion as judged by a five-item behavior score.
oratory. Average bias (mean difference be- Assessment of the Ability of Young 46 newborn babies on mechanical ventilation
tween lab value and CIABG). precision (SD of Children To Use a Powder Inhaler Device for respiratory distress syndrome were ran-
difference), and drift (change in the bias with —
(Turbuhaler) A Gorcn, N Noviski, A domly assigned to receive midazolam (n = 24)
time) were determined. RESULTS: At arterial Avital, C Maayan, E Stahl, S Godfrey, C or placebo (n = 22) as a continuous infusion.
oxygen tension (Pq,) values of 32-528 mm Hg. Springer. Pediatr Pulmonol 1994:18:77. Doses of midazolam were calculated to obtain
the average bias was - % meaning1 that the plasma concentrations between 200 and 1000
average CIABG monitor values were 1% The puq»se of the study was to delermine the ng/niL within 24 h of starting treatment and to
lower than those obtained by conventional age at which young asthmatic children could maintain these values throughout the study.
equipment. The precision was 15%. At arterial master the use of a new powder inhaler device Haemodynamic and ventilatory variables were
Pf). values of 32-99 mm Hg, average bias and (Turbuhaler). We studied 59 children with noted every hour, as were complications and
precision were -0.3 ± 8.9 mm Hg. Al arterial asthma between the ages of 3 and 6 years who possible side-effects of treatment. Mean (SD)
carbon dioxide tension (Pco;) values of 24-54 consecutively attended the asthma clinic of the duration of inclusion was 78.7 (30.9) h. I pa-
mm Hg, average bias and precision were 1 .3 ± pediatric department. Efficiency of inhalation tient in the trealnienl group and 7 in the place-
economically bring accuracy andl:ontrol to your sleep disorders testing needs while-^increasing. _.._,_,_
your productivity as you work more intuitively with the computer. ^ —— -
pediatric applications , .-
The SleepUih lOOOl' Transport Configuralioii - a powerful yet imprOVC yOUr productivity
economical system to meet yoin- clemiindiiig needs.
CNS, Inc. • 1250 Park Road • Chanhassen, MN 55317 • 612-474-7600 • 612-474-6737 (fax)
In Europe: Erich Jaeger GmbH Germany • 49 931 4972 • 49 931 4972 46 (fax)
CAREER bo group were withdrawn because of inade- the questions of pressure limitation with or
quate sedation (p < 0.05). Midazolam gave a without hypercapnia. the pathophysiologic ef-
OPPORTUNITIES significantly better sedative effect than place- fects of hypercapnia, or the concept of ventila-
duced by treatment but remained within the included. DATA EXTRACTION: Data were
RESPIRONICS, normal range for gestational age and there was analyzed with particular emphasis on obtaining
no effect on ventilatory indices. The incidence the following variables from the clinical stud-
INC. of complications was similar in the two groups. ies: peak inspiratory pressures, tidal volumes,
No midazolam-related side-effects were noted. minute ventilation, and Pco;- Quantitative as-
Respironics a leader in the
Inc.,
Continuous infusion of midazolam at doses pects of respiratory physiology were used to
development of non-invasive
respiratory care technologies, adapted to gestational age induces effective se- analyze the theoretical effects of permissive
has career opportunities for Cli- dation in newborn babies on mechanical venti- hypercapnia on ventilatory requirements in
nicians, Sales Representatives, lation, with positive effects on haemodynamic normal and injured lungs. DATA SYNTHE-
and Engineers. Positions are variables. The course of the respiratory distress SIS: Extensive animal model data support the
available at our corporate head- syndrome was not influenced by this treatment. hypothesis that ventilator-driven alveolar
quarters located in the rolling Midazolam was given over only a few days overdislention can induce significant
foothills of the Allegheny Moun- and the limited effects on heart rate and blood parenchymal lung injury. The heterogeneous
tains, 20 miles east of Pitts- pressure that we report should not encourage nature of lung injury in adult respiratory dis-
burgh, Pennsylvania. National long-term administration. tress syndrome, with its small physiologic lung
and international opportunities
volume, may render the lung susceptible to this
exist for Sales Representatives.
The Effect of Frequency on Carbon Dioxide type of injury through the use of conventional
Consider a career with an out- Levels during High Frequency Oscillation — tidal volumes (10 to 15 mL/kg). Permissive hy-
standing organization that is V Chan, A Greenough. J Perinat Med percapnia is an approach whereby alveolar
based on teamwork, and a com- 1994;22:I05. overdislention is minimized through either
mitment to its customers and pressure or volume limitation, and the potential
employees. We offer competi- The aim of this study was to assess if, during deleterious consequences of respiratory acido-
tive salaries and benefits pro- high frequency oscillation (HFO), a frequency sis are accepted. Uncontrolled human trials of
grams, educational assistance, of 10 or 15 Hz was associated with lower car- explicit or implicit permissive hypercapnia
profitsharing, and the chance
bon dioxide levels. Twelve infants were re- have demonsttated improved survival in com-
to work with some of the finest
cruited, median gestational age 27 weeks. All parison with models of predictive mortality.
people in the industry.
infants were studied at both frequencies, ap- CONCLUSIONS: Avoidance of alveolar
you are interested, please
If plied in random order and the carbon dioxide overdislention through pressure or volume lim-
forward your resume to: level checked after 30 minutes on each fre- itation has significant support based on animal
quency. Carbon dioxide levels were lower in models and computer simulation. Deleterious
Respironics, inc. 10 of the 12 infants at 10 compared to 15Hz(p effects of the associated hypercarbia in severe
Human Resources < 0.004) and, in the study population, overall lung injury do not appear to be a significant
Department were significantly lower at 10 Hz (p < 0.05). limiting factor in preliminary human clinical
The difference in Paco: levels at the two fre- trials. Although current uncontrolled studies
1001 iVIurry Ridge Drive
quencies, however, was small, thus these re- suggest benefit, controlled trials are urgently
Murrysville, PA 15668-8550 sults suggest the clinician should rely primarily needed to confirm these findings before adop-
Attention: iVlJZ on changes in oscillatory amplitude, rather tion of the treatment can be endorsed.
to Noon, and from 1 :30 P.M. to the basis of current theories of ventilator-in- the hospital housing the ICU, specialist status
5:30 P.M. and on Tuesday, De- duced lung injury, potential complications of (pediatric intensivist). and unit coordination.
cember 13, from 8:00 A.M. to systemic hypercarbia. and available human DESIGN: After a national survey, consecutive
Noon. Appointments may also outcome studies. DATA SOURCES: Articles case series were collected at 16 sites randomly
be made for Monday evening were identified through MEDLINE, reference selected to represent unique combinations of
and Tuesday afternoon. An citations of published data, and consultation quality-of-care factors. SETTING: Pediatric
Equal Opportunity Employer with authorities in their respective fields. ICUs. PATIENTS: Consecutive admissions to
M/F/D/V.
S TLIDY SELECTION: Animal model experi- each .site. MAIN OUTCOME MEASURE:
mcnlalion and human clinical trials were se- Patient mortality adjusled for physiologic sta-
Icclcd on the basis of whether thcv addressed tus, diagnosis, and other mortalitv risk factors.
RESPIRONICS INC.
'
'-"^
Circle 1 39 on reader service card RESPIRATORY CARE • NOVEMBER "94 Vol ?<9 No 1 1
QX/CL/Q* or the Sensor Recycling Program, to a selection For more information, contact your local representative
of reusables for your short-term needs, Nellcor sensors or call 1-800-NELLCOR or 510-463-4000. Internationally,
are there when you need them. call our European office in the Netherlands at +31.73.426565
In addition, compatibility with monitoring systems* from or our Asia/Pacific office at
7-94 'Check individual manufacturen for compatibility of particular instniments and si l.\;5£.\'HIA', jnd ( CLIQ are ltademari<s of Nellcor Incorpotated. © 1994 Nellcor Incorporated- All rights
ABSTRACTS
RESULTS: There were 5415 pedialric ICU ad- of dying, 1.79: 95% confidence interval [CI|. be associated, or may be negatively associated,
ICU deaths. The ICUs dif-
missions and 248 1.23 to 2.61; p = 0.002). In contrast, the proba- with quality of care in specialized care areas,
fered significantly with respect to descriptive bility of patient .survival after hospitalization in including the pediatric ICU.
variables, including mortality (range. 2.2% to an ICU with a pedialric intensivist was im-
16.4<7r). Analysis of risk-adjusted inortality in- proved (relative odds of dying, 0.65; 95% CI, Effect of Aerosolized Recombinant Human
dicated that the hospital teaching .status and the 0.44 to 0.95; p = 0.027 ). Post hoc analysis indi- DNase on Exacerbations of Respiratory
presence of a pediatric intensivist were signifi- cated that the higher severity-adjusted mortali- Symptoms and on Pulmonary Function in
cantly associated with a patient's chance of ty in teaching hospitals may be explained by Patients with Cystic Fibrosis— HJ Fuchs. DS
survival. The probability of patient survival the presence of residents caring for ICU pa- Borowilz. DH Christiansen, EM Morris. ML
after hospitalization in an ICU located in a tients. CONCLUSION: Characteri.stics indica- Nash, BW Ramsey, et al. for the Pulmozyme
teaching hospital was decreased (relative odds tive of the best overall hospital quality may not Study Group. N Engl J Med 1994;331(I0):637.
PneuViet^
TESTING & TRAINING SYSTEMS
recurrent, symptomatic exacerbations. The
coelasticity of the secretions can be reduced in
vitro by recombinant human deoxyribonucle-
vis-
Evaluation (APACHE HI). Simplified Acute SIONS: All models were based on rigorous re-
Physiology Score (SAPS 111. and Mortality search and reported performance is good. All
Probability Models (MPM II) are the major can be used to assist in assessing prognosis, to
severity systems for ICU patients. DATA EX- compare ICU performance, and to stratify pa-
TRACTION: Information on variables collect- tients for clinical trials. Direct comparison on a
ed in the systems, characteristics of databases common cohort is needed.
from which they were developed, and reported
performance of models were evaluated from Transmission of Mycobacterium tuberculosis
published articles. DATA SYNTHESIS: Associated with Air Travel —CR Driver, SE
APACHE III and SAPS II produce a score and Valway, WM Morgan, IM Onorato, KG
probability of hospital mortality based on Castro. JAMA 1994;272( 13): 10.^1.
24. 48. and 72 hours into the ICU stay. The craft from a crew member with tuberculosis.
SAPS II and MPM II models can be imple- DESIGN: Retrospective cohort study and sur-
mented from published information. The vey. SETTING: A large US airline carrier.
APACHE III score can be calculated from PARTICIPANTS: A total of 212 crew mem-
published information; weights to convert bers and 59 passengers who were exposed to a
score to probability are proprietary. All report- crew member with tuberculosis during a poten-
ed good areas under receiver operating charac- tially infectious period (May through October
teristic curve. Goodness of fit was good for 1992). Comparison volunteer sample of 247
SAPS II and MPM II models and was not re- unexposed crew members. MAIN OUTCOME
poned for APACHE III models. CONCLU- MEASURES: Positive tuberculin skin test
EVERYONE'S CONCERN!
MEDICAL COSTS • MEDICAL WASTE • PERSONNEL SAFETY
with agitation!
NO DRIP!
NO FUSS!
NO MUSCLE!
Mercedes-Benz* cars are renowned for comfort, So why make critically ill patients supply their own heat
safety and high performance. Just like our humidifiers. and humidity, when they could have it delivered?
Bicycles, on the other hand, will only get you some- For further information, and detailed cost
where if you're fit enough to pedal. And comparisons, ring Baxter toll-free from anywhere in
f^^soil^^^ that reminds us of passive devices, which the US on 1-800-321-3832, or speak to us direct on
*" "
'
^^
our humidifiers all the time
that of u.sing alternati\e systems.
is no more than
Fisher ^Pdykel
Fisher & Paykel Healthcare: 25 Carbine Road P.O. Box 14-348 Panmure, Auckland NEW ZEALAND Tel: +64-9-570 5655 Fax: +64-9-570 9500.
Changes in cardiac output were independent of with abnormal lungs treated with HBOi. For
lung compliance and concurrent vasoactive clinical reasons, we measured the PaO; of 24
drug support. No consistent ciiange was noted An Announcement Of Importance
patients treated with HBOi. We obtained arte-
in either blood pressure or heart rate. CON-
CLUSIONS: Lung hyperintlation is frequently
rial blood gas values from patients with lung to l{ESPifimYCMMw\mi
dysfunction (a/A < 0.75) prior to, during, and
not achieved by the manual technique.
after HBO;. The pre-HBO: a/A = 0.45 ±0.17 Effective with the November 1994 issue,
Significant changes in cardiac output can occur Williams & Wilkins will be the official advertis-
(mean ± I SD). During HBOi the a/A ranged
and appear to be related to the tidal volume ing sales representative for HSPKAJORY Cut.
from 0.7 to 0.8 depending on chamber pressure
rather than pressure generated.
and returned to the pre-HBOi baseline after Daedalus has selected Williams & Wilkins be-
Oxygen Tension of Patients with
.Arterial HBOi. We conclude the following: ( 1 ) The hy- cause of its international leadership and expe-
rience in medical and health science advertis-
.Abnormal Lungs Treated with Hyperbaric perbaric PjO;S of patients with a/A < 0.75 is
ing sales representation. We believe that this
Oxygen Is Greater Than Predicted LK — greater than expected. (2) However, the PaO: is
experience, coupled with the extra services
Weaver, S Howe. Chest 1994:106:1 134. lower than in patients with normal lung func- offered by Williams h Wilkins and their repu-
tion (a/A > 0.75). Possible explanations in- tation for being "advertiser friendly," will help
The arterial oxygen (O;) tension (Pao,) of pa- you succeed in the promotion of your prod-
clude improvement in ventilation/perfusion
tients with normal gas exchange treated with ucts and services.
matching, reduction of venous admixture,
hyperbaric oxygen (HBO:) can be predicted
and/or extraalveolar uptake of Oi. (3) Your new/ Advertising Representative is
from their pre-HBOi arterial to alveolar O:
Exposures to HBO: treatment pressures Gregory |. Pessagno
tension ratio (a/A) which remains constant up
greater than recommended by existing proto-
National Sales Manager, HSPKATORY On
to a PaO: of 2,000 mm Hg. We observed that (410)528-4218
the a/A could not be used to predict the PaO; of cols may be required in patients with impaired 428 E. Preston St.
patients with impaired gas exchange (reduced transfer of O: across the lung to achieve PaOjS Baltimore, MD 21 202-3993
pre-HBO: a/As) treated with HBOi. Our study similar to patients with normal lung function Fax (410) 528-4452
A'Tormula"ToFightThe _
OQUE£Z£l
OUR CPR BAG SIX EXTRA MERCURY MEDICAL®
INCHES IN VERSATILE CPR BAG
LENGTH
Omni Link II
more information. MERCURY MEDICAL" Omni Link II allows flexible maneuvering in any direction
withiHit adding dead space. With the Omni-Link II attached to the Mercury Complete
Personal Resuscilator, the immediate patient area can become less of a liahl xi/iicczc situation.
The Onini-Link II also permits the patient to be moved without interrupting resuscitation.
ME RCURY
MEDICAL*^
Don't lock yourself into a
MERCURY MEDICAL* Omni-Link
(/.i;/i/ .vc/i/ccrc situation.
II.
Take control. Call lodav to order vour
11300 A - 49th Street North • Clearwater, FL 34622-4800 • TEL (800) 237-6418 • FAX (813) 573-6040
Twice-Daily
Sere\^f
(solmeferol xinofoote)
Inhalation Aerosol
Morning and Evening Inhaiation
for Active Days and Restful Nigiits
some
84), the mean
patients used
daily
more
need for additional beta2-agonist use
Eight percent of patients used at least eight inhalations per
was 1 to 1
clinical
V2 inhalations per
(salmeterol xinafoate) day at least on one occasion Six percent used 9 to 12 inhalations at least once. There were 15
Inhalation Aerosol patients (8%) who averaged over four inhalations per day Four of these used an average of 8 to
1 1 inhalations per day In these 1 5 patients there was no observed increase in frequency of car-
diovascular adverse events The safety of concomitant use of more than eight inhalations per day
Bronchodilator Aerosol
of short-acting beta2-agonists with Serevent" (salmeterol xinafoate) Inhalation Aerosol has not
For Oral Inhalation Only
been established. In 1 5 patients who experienced worsening of asthma while receiving Serevent
The following summary Inhalation Aerosol, nebulized albuterol (one dose in most) led to improvement in FEV, and no
is a brief only. Before prescribing, see complete prescribing information
in Serevent' Inhalation Aerosol product labeling increase in occun'ence of cardiovascular adverse events
Monoamine Oxidase Inliibitors and Tricyclic Antidepressants: Salmeterol should be adminis-
CONTRAINDICATIONS: Serevent' Inhalation Aerosol is contraindicated in patients with a history
tered with extreme caution to patients being treated with monoamine oxidase inhibitors or tncycllc
of hypersensitivity to any of the components.
antidepressants because the action of salmeterol on the vascular system may be potentiated by
WARNINGS; 1 Not for Use to Treat Acute Symptoms: Watch for Increased Need for Short-Actino these agents.
Beta ? -Aoonists: Serevent' Inhalation Aerosol should not be used to relieve acute asthma symp- Corticosteroids and Cromoglycate: In clinical trials, inhaled corticosteroids and/or inhaled
toms. If the patient's short-acting, inhaled beta^-agonist becomes less effective, e g , the patient cromolyn sodium did not alter the safety profile of Serevent Inhalation Aerosol when administered
needs more inhalations than usual, medical evaluation must be obtained immediately and concurrently.
increasing use of Serevent Inhalation Aerosol m this situation is inappropriate Serevent Inhalation Methylxanthines: The concurrent use of intravenously or orally administered methylxanthines
Aerosol should not be used more frequently than twice daily (morning and evening) (eg., aminophylline, theophylline) by patients receiving Serevent Inhalation Aerosol has not been
at the recommended dose When prescribing Serevent Inhalation Aerosol, patients must be completely evaluated In one clinical trial, 87 patients receiving Serevent Inhalation Aerosol 42
provided with a short-acting, inhaled betaj-agonist |e g ,
albuterol) for treatment of symptoms meg twice daily concurrently with a theophylline product had adverse event rates similar to those
that occur despite regular twice-daily (morning and evening) use of Serevent in 71 patients receiving Serevent Inhalation Aerosol without theophylline Resting heart rates
Asthma may deteriorate acutely over a period of hours or chronically over several days. In this were slightly higher in the patients on theophylline but were little affected by Serevent Inhalation
setting, increased use of inhaled, short-acting beta2-agonists is a marker of destabilization of Aerosol therapy
asthma and requires re-evaluation of the patient and consideration of alternative treatment regi-
Carcinogenesis, Mutagenesis, Impairment of Fertility: In an 18-month oral carcinogenicity
mens, especially inhaled or systemic corticosteroids. If the patient uses four or more inhalations
study in CD-mice, salmeterol xinafoate caused a dose-related increase in the incidence of
per day of a short-acting bela2-agonist on a regular basis, or if more than one canister (200
smooth muscle hyperplasia, cystic glandular hyperplasia, and leiomyomas of the uterus and a
inhalations per canister) is used in an 8-week period, then the patient should see the pliysician
dose-related increase in the incidence of cysts in the ovaries. A higher incidence of leiomyosarco-
for re-evaluation of treatment
mas was not statistically significant: tumor findings were observed at oral doses of 1 .4 and 10
2 Use With Short-Actinq Beta j -Aoonists, When patients begin treatment with Serevent
mg/kg. which gave 9 and 63 times, respectively, the human exposure based on rodent:human
Inhalation Aerosol, those who have been taking short-acting, inhaled beta2-agonists on a regular
AUC comparisons.
daily basis should be advised to discontinue their regular daily-dosing regimen and should be
Salmeterol caused a dose-related increase in the incidence of mesovarian leiomyomas and
use short-acting, inhaled beta^-agonists only for symptomatic relief if they
clearly instructed to
ovarian cysts in Sprague Dawley rats in a 24-month inhalation/oral carcinogenicity study Tumors
develop asthma symptoms while taking Serevent Inhalation Aerosol (see PRECALITIONS: Drug
were observed in rats receiving doses of 0.68 and 2 58 mg/kg per day (about 55 and 21 5 times
Interactions)
the recommended clinical dose [mg/m^]) These findings in rodents are similar to those reported
3. Serevent Inhalation Aerosol Is Not a Substitute for Oral or Inhaled Corticosteroids: Patients
previously for other beta-adrenergic agonist drugs The relevance of ttiese findings to human use
must be warned not to stop or reduce corticosteroid therapy without medical advice, even if they
IS unknown
feel better when they are lieing treated with Serevent
No significant effects occurred in mice at 2 mg/kg (1 3 times the recommended clinical dose
4- Do Not Exceed Recommended Dose: As with other beta-adrenergic aerosols. Serevent
based on comparisons of the AUCs) and in rats at 0.21 mg/kg (1 5 times the recommended clini-
Inhalation Aerosol should not be used in excess Fatalities have been reported in association with
caldose on a mg/m2 basis).
excessive use of inhaled sympathomimetic drugs Large doses of inhaled or oral salmeterol (12
Salmeterol xinafoate produced no detectable or reproducible increases in microbial and mam-
to20 times the recommended dose) have been associated with clinically significant prolongation
malian gene mutation No blastogenic activity occurred m vitro inhuman lymphocytes or
in vitro.
of theQTq interval, which has the potential for producing ventricular arrhythmias
in vivo in a rat micronucleus No effects on fertility were identified in male and female rats
test.
5. Paradoxical Bronchospasm: As with other inhaled asthma medications, paradoxical
treated orally with salmeterol xinafoate at doses up to 2 mg/kg orally (about 1 60 times the rec-
bronchospasm (which can be life-threatening) has been reported following the use of Serevent
ommended clinical dose on a mg/m^ basis)
Inhalation Aerosol If it occurs, treatment with Serevent Inhalation Aerosol should be discontinued
immediately and alternative therapy instituted Pregnancy: Teratogenic Effects: Pregnancy Category C: No significant effects of maternal
Immediate Hypersensitivity exposure to oral salmeterol xinafoate occurred in the rat at doses up to the equivalent of about
6, fieactions. Immediate hypersensitivity reactions may occur after
1 60 times the recommended clinical dose on a mg/m2 basis Dutch rabbit fetuses exposed to
administration of Serevent Inhalation Aerosol, as demonstrated by rare cases of urticaria, rash,
and bronchospasm. salmeterol xinafoate in ufero exhibited effects charactenstically resulting from beta-adrenoceptor
stimulation; these included precocious eyelid openings, cleft palate, sternebral fusion, limb and
PRECAUTIONS: paw flexures, and delayed ossification of the frontal cranial bones. No significant effects occurred
General: 1 Us e with Spacer The safety and effectiveness of Serevent®
or Other Devices: at 0,6 mg/kg given orally (12 times the recommended clinical dose based on companson of the
Inhalation Aerosol when used with a spacer or other devices have not been adequately studied. AUCs).
2 Cardiovascular and Other Effects: No effect on the cardiovascular system is usually seen New Zealand White rabbits were less sensitive since only delayed ossification of the frontal
after the administration of inhaled salmeterol in recommended doses, but the cardiovascular and bones was seen at 1 mg/kg given orally (approximately 1 .600 times the recommended clinical
central nervous system effects seen with all sympathomimetic drugs (eg , increased blood pres- dose on a mg/m2 basis) Extensive use of other beta-agonists has provided no evidence that
sure, heart rate, excitement) can occur after use of Serevent Inhalation Aerosol and may require these class effects in animals are relevant to use in humans There are no adequate and well-
discontinuation of the drug Salmeterol, like all sympathomimetic amines, should be used with controlled studies with Serevent Inhalation Aerosol in pregnant women. Serevent Inhalation
caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac Aerosol should be used dunng pregnancy only if the potential benefit justifies the potential risk to
arrtiythmias, and hypertension, in patients with convulsive disorders or thyrotoxicosis; and in the fetus.
patients who are unusually responsive to sympathomimetic amines.
Use in Labor and Delivery: There are no well-controlled human studies that have investigated
As has been described with other beta-adrenergic agonist bronchodilators, clinically significant effects of salmeterol on preterm labor or labor at term. Because of the potential for beta-agonist
changes in systolic and/or diastolic blood pressure, pulse rate, and electrocardiograms have interterence with uterine contractility, use of Serevent Inhalation Aerosol during labor should be
been seen infrequently in individual patients in controlled clinical studies with salmeterol restricted to those patients in whom the benefits clearly outweigh the risks
3. Metabolic Etfi;cts_ Doses of the related beta2-adrenoceptor agonist albuterol, when adminis- Nursing Mothers: Plasma levels of salmeterol after inhaled therapeutic doses are very low (85 to
tered intravenously, have been reported to aggravate pre-existing diabetes mellitus and ketoaci-
200 pg/mL) in humans. In lactating rats dosed with radiolabeled salmeterol. levels of radioactivity
dosis No effects on glucose have been seen with Serevent Inhalation Aerosol at recommended
were similar in plasma and milk. In rats, concentrations of salmeterol in plasma and milk were
doses Administration of beta2-adrenoceptor agonists may cause a decrease in serum potassi-
similar The xinafoate moiety is also transferred to milk in rats at concentrations of about half the
um, possibly through intracellular shunting, which has the potential to increase the likelihood of
corresponding level in plasma. However, since there is no expenence with use of Serevent
arrhythmias The decrease is usually transient, not requiring supplementation
Inhalation Aerosol by nursing mothers, a decision should be made whether to discontinue nursing
Clinically significant changes in blood glucose and/or serum potassium were seen rarely dur-
or to discontinue the drug, taking into account the importance of the drug to the mother Caution
ing clinical studies with long-term administration of Serevent Inhalation Aerosol at recommended should be exercised when salmeterol xinafoate is administered to a nursing woman
doses.
Pediatric Use: The safety and effectiveness of Serevent Inhalation Aerosol in children younger
Information for Patients: See illustrated Patients Instructions for Use. SHAKE WELL BEFORE than 12 years of age have not been established.
USING. Patients should be given the following information:
Not..fgr Use to Treat Acute Sympt oms: Serevent Inhalation Aerosol is not meant to relieve
Geriatric Use: Of the totalnumber of patients who received Serevent Inhalation Aerosol in all
1
clinical studies. 241 were 65 years and older Geriatric patients (65 years and older) with
acute asthmatic symptoms Acute symptoms should be treated with an inhaled, short-acting
reversible obstructive airway disease were evaluated in four well-controlled studies of 3 weeks'
bronchodilator that has been prescribed by a physician for symptom relief.
to 3 months' duration. Two placebo-controlled, crossover studies evaluated twice-daily dosing
2. Dj^Not Exceed Recommended Dose, The bronchodilator action of salmeterol usually lasts
with salmeterol for 21 to 28 days in 45 patients. An additional 75 geriatric patients were treated
for at least 1 2 hours therefore it stiould not be used more often than every 1 2 hours.
with salmeterol for 3 months in two large parallel-group, multicenter studies. These 120 patients
3. !Js_e with Other While using Serevent Inhalation Aerosol, other inhaled medi-
ti/ledications.
cines should be taken only as directed by the physician
experienced increases in AM
and PM peak expiratory flow rate and decreases in diurnal variation
in peak expiratory flow rate similar to responses seen in the total populations of the two latter
4. Use w ith Short-Acting. Inhjiled Bela-Agqnisis: While using Serevent Inhalation Aerosol,
studies The adverse event type and frequency in geriatric patients were not different from those
medical attention should be sought immediately if the short-acting bronchodilator treatment
of the total populations studied
becomes less effective for symptom relief, if more inhalations than usual are needed, or if more
No apparent differences in the efficacy and safety of Serevent Inhalation Aerosol were
Uian the maximum number of inhalations of short-acting bronchodilator treatment prescribed for
observed when genatrc patients were compared with younger patients in clinical trials As with
a 24-hour period are needed. II the patient uses four or more inhalations per day of a short-act-
on a regular basis, or
other bela2-agonists, however, special caution should be observed when using Serevent
ing beta2-agonist if more than one canister (200 inhalations per canister) is
an e-week period, then the patient should see the physician
Inhalation Aerosol in elderly patients who have concomitant cardiovascular disease that could be
used in for re-evaluation of treat-
adversely affected by this class of drug. Based on available data, no adjustment of salmeterol
ment
dosage in geriatric patients is warranted
Patients should be cautioned regarding potential adverse cardiovascular effects, such as palpi-
tations or chest pain, related to the use of additional beta2-agonist ADVERSE REACTIONS: Adverse reactions to salmeterol are similar in nature to reactions to other
5. Use of S y stemic or Inhaled Steroids Serevent Inhalation Aerosol
: does not replace oral or selective beta2-adrenoceptor agonists.e.. tachycardia; palpitations; immediate hypersensitivity
1
inhaled corticosteroids; the dosage of these medicines should not be changed and they should bronchospasm (see WARNINGS); headache; tremor: nervous-
reactions, including urticaria, rash,
not be stopped without consulting the physician, even if the patient feels better ness; and paradoxical bronchospasm (see WARNINGS)
6. Use for Exe rcise-Induced Bronchospasm: When using Serevent Inhalation Aerosol to prevent Two multicenter. 12-week, controlled studies have evaluated twice-daily doses of Serevent'
exercise-induced bronchospasm. the dose should be administered at least 30 to 60 minutes Inhalation Aerosol in patients 1 2 years of age and older with asthma The following table reports
before exercise. the incidence of adverse events in these two studies.
Circle 126 on reader service card
Visit AARC Booth 115 in Las Vegas
With the
Information Get acquainted kit for RCPs
Service Card,
YOU CAN Four books and two diary sheets
STOP SEARCHING
AND (a $30 value) for $10:
START BUYING. • Children with Asthma
Get the facts on all the • One Minute Asthma
products and services
adverti.sed
• One Minute Asthma (Spanish)
in this issue • Winning Over Asthma
easily and quickly.
The computerized
• Asthma Peak Flow Diary sheet
Information • Astlima Signs Diary sheet (1 /95)
Service Card does it all.
Simply fill in your name and Send check or purchase order to Pedipress, Inc.,
125 Red Gate Lane, Aniherst, MA 01002
address, check the
appropriate boxes,
and mail or fax it.
One kit per ciddress • Offer expires 12/31/95 • U.S. orders only
s .
On January 17, 1994 at 4:31 care for other patients, but one of the
a. m. , the lights went out at St. Adult Stars was ventilating a young
Johns Hospital in Santa Monica, woman with ARDS. She would not
California. A 6. 8 magnitude earth- have been a good candidate for
"
quake rocked the Los Angeles basin, sustained hand bagging.
shutting down both the hospital' Although natural disasters are the
main and auxiliary power units. exception, brown outs and power
"All of our ventilators stopped outages are occurring with increasing
operating, except for the Adult Stars frequency. Be safe with Infrasonics
. which didn't miss a breath, " said
. . Star ventilators. You' 11 have the
John Denny RRT, equipment coordi- added protection of automatic battery
nator for the hospital. "Not only did operation when the lights go off . .
Infrasonics, Inc.
A Public Company
Visit AARC Booth 737 in Las Vegas Circle 120 on reader service card
.
Peak
Monitoring
Patented flow-sampling
technology minimizes
wear... maximizes
accuracy and
reproducibility
Sterilizable.
dishwasher-safe
moving parts
effective
ABS
— for
performance
plastic
construction, surgical stainless steel
reliable, cost-
\ V V , , \ V » V , \ V
llll\\\\l\ \ \ \
\ \ \ \ \
sterilizable/
^^ \
rB^tdCUtdl /JCdi® Peak Flow Meter
disposable \
Redefining peal< flow monitoring.
mouthpieces make i 1 want to experience the Personal Best difference first-hand
multi-patient
screening a snap.
Clly
HealthScan Products Inc. • 908 Pompton Avenue • Cedar Grove, NJ 07009-1292 USA
1-800-962-1266 FAX (201) 239-0831
Daedalus Enterprises has appointed
Williams & Wilkins as the contact
for your classified recruitment ads.
AARC Tunes and Respiratory Care: Efficient; at a cost of a fraction of a penny.
Publications that are read and retained. Effective; reaching 37,000 respiratory care
practitioners.
The best classified ads in respiratory care;
helping you find the best qualified Call for new lower rates and closing dates for
respiratory care practitioners. your classified advertising.
Contact Jim Burke at (800) 528-1843. AARC Times and Resi'IRATORY Cark, 428 E. Preston Street, Baltimore, MD 21202.
Now
monary and peripheral blood flow. We de\ ised a double-blender system for controlling
the delivered CO2 (Fdco:) and oxygen concentrations (Fdo;) and evaluated the utility of
a nomogram to predict blender settings for required gas concentrations. DESCRIP-
TION OF DEVICE: Two Bird 3800 MicroBlenders were connected in series. The first
(a) was supplied by CO2 and air and fed into the second blender (/3), which was also sup-
plied by O2. System equations were derived and a nomogram constructed to predict set-
tings for desired Fdcx): and Fdo: expressed as CO. % and O2 %. EVALUATION METH-
ODS: Values predicted using the nomogram were compared to measured values.
Analyzers were calibrated with standard gases. Blender calibrations were verified. Using
nomogram-derived blender settings. 4 levels of O2 (21. 40. 60, and 80% and 2 levels of
)
CO2 (25 or 30% ). in random order, were analyzed in triplicate. The mean and standard
deviation of differences (predicted - measured values) were used to estimate inaccuracy
intervals that would include 95% of future observations at the 99% confidence level.
Childrens Hospital —Cleveland Ohio. cooling before bypass decreases the metabolic rate and CO:
production, which may further contribute to reduced PacO:-
A version of this paper will be presented by Ms Anderson during the Attempts to maintain PacO: at the desired level by reducing
RESPIRATORY Care OPEN FORUM at the 1994 AARC Annual tidal volume (Vj), respiratory rate (f), or both often result in
Meeting, to be held in Las Vegas, Nevada, December 10-13, 1994.
arterial desaturation.- It has been hypothesized that desatura-
tion occurs because of decreased functional residual capacity
Reprints: Robert L Chatburn, Director, PediaUic Respiratory Care,
(FRC), closure of small airways, atelectasis, and hypoxemia.-
Rainbow Babies & Childrens Hospital, 1 1 100 Euclid Ave, Cleveland
OH 44106. Maintaining FRC with appropriate Vj and f minimizes these
CM
O
oo
0)
>
3
o
Setting (%)
10 CO2 Blender
a'
I
I
I '
I
'
I
'
M I ' I
'
I
' I ' I ' I I
'
10 5
Example
1 Draw vertical line through desired CO2 (eg, line a, a' at 7%).
2. Draw horizontal line through desired O2 (eg, line b, b' at 48%).
3. Draw line from intersection of first two lines to O2 Blender Setting scale (eg, line c, c' at about 50%). This line should be
parallel to CO2 Blender Setting scale and perpendicular to O2 Blender Scale.
4. Find isopleth closest to intersection of three lines. Read down along isopleth to CO2 Blender Setting scale (eg, 31%).
Fig. 2A. Illustration of the application of a nomogram for predicting oxygen and carbon dioxide concentrations for various settings of the dou-
ble-blender system.
100 -^
90 —
80
^
o^
CONTROLLING CARBON DIOXIDE DELIVERY DURING MECHANICAL VENTILATION
inspect for outliers and to check that measured values were not value - measured value, so that if the difference is positive we
associated witli the measurement level, as detemiined by a corre- can say that the predicted value overestimates the true value
lation coefficient.'" The hypothesis tliat the correlation coefficient and vice versa). Therefore, the error interval can be interpreted
was not different from zero was tested with Fisher's tiansforma- as an inaccuracy intenxd. The value of k in liquation 3 was se-
tion.'' Outliers were defined using a mcxiified Thompson t tech- lected froin standard tolerance limit tables" to include 95% of
nique^ as any value greater than 1 .9 standard deviations away future observations at the 99% confidence level. This value
from the mean value, based on a sample size of 24 and a 95% was 2.972 for a sample size of 24.
confidence level.
Results
Step 2. The construction of symmetrical enor intervals based on
standard deviations assumes that the data confomi to a nomial or The results of the blender calibration verification procedure
Gaussian distribution. This assumption was confimied using the are shown in Table 1 . Both blender dials tended to overesti-
Kolmogorov-Smimov test. mate the delivered oxygen concentration, particularly at the
the measured
cept proposed by these authors is only a point estimate, which
includes simplifications that may not always apply, particularly Table 1 . Results of Blender Calibration Verification Using Air and
for sample sizes less than 30.'' An alternative is to calculate an Oxygen Inputs (Manufacturer's Error Specification ±3%)
error inteival. '"
The error interval is based on the concept of
tolerance intervals, which are extremely important in evaluat-
ing production and quality in manufacturing and service indus-
tries."'- The error interval takes into account the uncertainty of
El = Xa ± kSDj. [.^1
0.75
0.5
0.25
-0.25
0.5
-0.75
-1
CONTROLLING CARBON DIOXIDE DELIVERY DURING MECHANICAL VENTILATION
8-
)
APPENDIX
Derivation of Blender Equations for Delivering O2-CO2 Mixtures
Assumptions: Fo; of air = 0.2 1 Fco: of . air = 0.0. to carbon dioxide inputs. Using Equation A4, we estimated
that the actual flow of carbon dioxide through the blender
would be SS'/f of the expected flow if oxygen were con-
The equations for both blenders were deri\'ed from basic mass nected, due to carbon dioxide's higher density:
balance equations:
Vcartx,„d,o<,do = (0.85)(Va„). 1A51
(F0..I I V,„,) = (Fo;) (V<,xyEC„l+ (FO;) {V„„ lAl]
_ 0.21(1 -setting)
Gas flow through a constriction is a function of density 0.822 -0.15 (setting)
fice, as in the blenders, the density of the gas plays a domi- where "setting" refers to the Fo; setting of the blender expressed as
nant role in determining the rate of flow. For an ideal ori- a decimal fraction.
density of Gas B
fashion:
now A
ctual of Gas
.V densilv of Gas A
)(no / expected through B meter)
|A41
0.85 a setting -0.1 78
^0.822-0.15 a setting [A8]
The density of oxygen is 32 g/mol and its viscosity is
201 micropoises. The density of carbon dioxide is 44
_ (1-/3 setting) (0.85 g setting - 0. 1 78
g/iTiol with a viscosity of 148 micropoises. The viscosities '*^°'" ' 0.822-0.15 a setting |A9]
of the two gases are not very different to begin with and as-
suming that density dominates flow, we ignored viscous
effects on blender calibration when switching from oxygen A more complete derivation is available upon request.
Mr Perry and Dr L^angeiiback ore from the Department of Medicine. tion and particle impaction (ie, with one-way valves^) that re-
Pulmonary Disease/Critical Care Division, State University of New duce the proportion of large nonrespirable particles and be-
York at Stony Brook, Stony Brook, New York. Dr Dowite is Director of cause it encourages slow inhalation of the medication.'''^ This is
Respiratory Care, Winthrop-University Hospital, Mineola, New York. typically achieved through the use of a flow sensor* that acti-
The authors have no fniancial interest in any of the products men- ization of the collapsing reservoir during inhalation."''^ Failure to
tioned in this paper or in any competing product. shake the MDI before use or to perform a sufficient breathhold
of the medication are. to date, not controlled by HC devices.
A version of this paper was presented by Mr Perry during the
The first HCs were well characterized in vitro and in vivo
Respiratory Care Open Forum at the 1993 AARC Annual
before being widely accepted.^'"'- New HC designs, howev-
Meeting, held in Nashville, Tennessee.
er, have been developed and distributed without thorough clin-
and Drug Administration approval that allows them to be mar- Then a new MDI was shaken, primed with 2 puffs,''' attached
keted in the United States. HCs are characterized in vitro by to the HC, and placed in the subject's mouth. The HC was
assay of total deposition/dose (etficiency). particle size distri- then charged with 1 puff of aerosol, and the subject inhaled
bution, and amount of aerosolized drug exiting each device slowly from residual volume to total lung capacity, held his
under predetermined sampling conditions. When four HCs breath for 5 seconds, and then exhaled normally. The second
with substantial design differences were compared in this puff was inhaled after a 1 -minute rest. FEV] was measured at
manner using an albuterol MDl aerosol, the data reported in an 30, 60, and 120 minutes after the second puff. In addition,
abstract by Dolovich et al" demonstrated differences among pulse, blood pressure, and incidence of side effects (includ-
the devices. Unfortunately, many of the factors that contiibute ing tremors, nervousness, dizziness, nausea, or headache)
to the clinical effectiveness of various HCs are not known, and were recorded before and after bronchodilator. The albuterol
some that are known may not be taken into account during in- canister was saved for use on the subsequent HC study day.
vitro testing. Therefore, we believe that the clinical equivalen-
cy of a particular device must be directly ascertained in vivo. Table 1. Specifications of Holding Chambers Selected for Study
suidy consisted of a clinical comparison in asthmatic subjects. Internal valve design Center opening Side opening
renal disease, or a metabolic disorder; were current smokers; was also performed to detemiine how sensitive our study
or were pregnant. The best of 3 trials to perform FEVi was was for detecting a meaningful difference between the two
our measure of reversibility and was made before (pre) and at HCs.
30, 60, and 120 minutes after (post) administration of al-
buterol using a small volume nebulizer (SVN)-compressor Results
the ACE and were instructed to reduce their inspiratory No differences were statistically significant for any time pe-
flowrate so as not to trigger the flow sensor. None triggered riod. The probabilities from the paired t test on ACE vs
the Aerochamber flow sensor. Aerochamber at 30 minutes was 0.068. at 60 minutes 0.056,
Using a randomized crossover study design, we then ad- and at 1 20 minutes 0.962. A post-hoc power analysis .showed
ministered 2 puffs of albuterol by MDI (90^g/puff) using the an 80% chance of detecting a 13% difference between %
ACE or Aerochamber HC. Specifications of the two HCs se- possible FEV|S (for each HC) at the 0.05 level of signifi-
lected for clinical evaluation are given in Table 1. Baseline cance. No patient experienced a significant change in heart
rev was I
performed, and the best of 3 efforts is reported. rale or blood pressure after bronchodilator by any method.
The incidence of side effects was minimal, with 1 patient ex-
*Manufacturers and suppliers are identified in the Product Sources sec- periencing headache and 1 patient experiencing dizziness
tion at the end of the text. both with albuterol by SVN.
Variable
.
InspirEase im the deposition of inetercd-dose aerosols in the human available from four MDl add-on devices (abstract). Am Re\ Respir
Inspiratory tract. Chest 1986:89(4):551-556. Dis 1993;I47:A996.
Newman SP. Millar AB, Lennard-Jones TR. Moren F. Clarke SW. Blake KV. Harman E. Hendeles L. Evaluation of a generic albuterol
ImproveiTient of pressurised aerosol deposition with Nebuhaler spacer metered-dose inhaler: importance of priming the MDl. Ann Allergy
device. Thorax 1 984;39( 2 ):935-94 1
1 1992:68(2): 169- 174.
Lawford P, McKenzie D. Does inspiratory flow rate affect bron- Knudson RJ, Slatin RC. Lebowitz MD. Burrows B. The maximal ex-
chodilator response to an aerosolized ft agonist (absu-act)'.' Thorax piratory flow-volume curve: normal standards, variability, and effects
1981:36:714. of age. Am Rev Respir Dis 1976:1 13(5):587-6(X).
Newman SP, Pavia D. Clarke SW. Simple instructions for using pres- Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the
surized aerosol bronchodilators. J R Soc Med 1980:73( I 0:776-779. normal maximal expiratory flow-volume curve with growth and
Perry RJ, Langenback EG. Bergofsky EH. llowite JS. Differences in aging. Am Rev Respir Dis 1983:127(6):725-734.
aerosol holding chamber flow sensors may alter MDl therapeutic ef- Dompeling E. van Schayck CP, Molema J, Akkermans R, Folgering
fect (abstract). .-Xm Re\ Respir Dis 1993:147(4. Part 2):A996. H, van Grunsven PM, van Weel C. A comparison of six different
Vichyanond P. Chokephaibulkit K, Kerdsomnuig S. Visitsuntom N, ways of expressing the bronchodilating response in asthma and
Tuchinda M. Clinical evaluation of the "Siriraj Spacer" in asthmatic COPD: reproducibility and dependence of prebronchodilator FEV|.
Thai children. Ann Allergy 1992:69(5):433-438. Eur Respir J 1992;5( 81:975-981.
Corr D. Dolovich M. McCormack D. Ruffm R, Obminski G. "Student." The probable error of the mean. Biometrika 1908:6:1.
Newhouse M. Design and characteristics of a portable breath actuated, Blake KV, Hoppe M, Harman E. Hendeles L. Relative amount of al-
particle size selective medical aerosol inhaler. J Aerosol Sci buterol delivered to lung receptors from a metered-dose inhaler and
1982;13:1-7. nebulizer solution: bioassay by histamine bronchoprovocation. Chest
1983:84(l):36-4i. metered dose inhaler ( MDl ) alone or with the Aerochamber or opti-
Dolovich M. Chambers C, Mazza M. Newhouse MT. Albuterol dose haler (abstract). J Allergy Clin Immunol 1993,91 ; 167.
CORRECTIONS
Errors were made in two Clinical Practice Guidelines printed in the August issue.
In the AARC Guideline: Application of Continuous Positive Airway Pressure to Neonates via Nasal Prongs or
Nasopharyngeal Tube Section 13.2 states "The Clinical Practice Guideline: Ventilator Circuit Changes, the
CDC, and reported experience suggest that use periods of < 5 days are acceptable when the humidifying device
is other than an aerosol generator." Section 13.2 should have read "suggest that use periods of > 5 days are ac-
ceptable when the humidifying device is other than an aerosol generator." j Error occurred on Page 820.]
Clinical Practice Guideline reprints have been coirected. We regret the errors.
Test %ur
Patricia A Doorley MS RRT and Charles G Durbin Jr MD. Section Editors Radiologic Skill
Case Summaries low secretions and of "pain in her neck." Her physical exam-
ination was negative for stridor, neck swelling, and tracheal
A 49-year-old Caucasian woman (Patient A), with a his- deviation. A lateral-neck radiograph (Fig. 1) was performed,
tory of aplastic anemia, presented to the Warren G and she was transferred to the medical intensive care unit.
Magnuson Clinical Center of the National Institutes of Another patient, admitted to our center, was a 5 -year-old
1
Health for the administration of anti-thymocyte globulin African- American woman (Patient B) admitted for adminis-
(ATG), cyclosporin A, and glucocorticosteroid therapy. Her tration of ATG, cyclosporin A, and glucocorticosteroids for
physical examination on admission revealed oral mucosal treatment of apla.stic anemia. Physical examination revealed
bleeding, facial ecchymoses. and menorrhagia. Laboratory vaginal and rectal bleeding. Her admission platelet count was
tests revealed a hemoglobin of 8.7 g/dL and a platelet count 3,000/mm' and hemoglobin 6.5 g/dL. Blood culture was pos-
of 3,000/mm\ In addition, blood cultures were positive for itive for Bacteroides fragilis and Clostridium species. Prior
an a-hemolytic streptococcus. On the fourth day after admis- to receiving her immunosuppressive therapy, she was admit-
sion, she continued to have vaginal bleeding with sponta- ted to the medical intensive care unit for placement of a cen-
neous mucosal hemorrhage, oral hematomas, and a new right tral venous catheter necessary for administration of ATG, cy-
periorbital hematoma. She complained of inability to swal- closporin A, glucocorticosteroids, and antibiotics. The right
In.stitutes of Health, 10 Center Drive, MSC 1662, Building 10, clavicle to the angle of the right jaw. An anteroposterior
Room 7D43, Bethesda MD 20892-1662. chest radiograph was performed (Fig. 2).
^ J| Learn the
Call (214) 243-2272 or Fax Your Order to (214) 484-2720 • American Association for Respiratory Care 11 030 • Abies Lane, Dallas, TX 75229-4593
quired.
Assessments of chest retractions, dyspnea, tachypnea, and
stridor are required to identify impending respiratory failure.
Discussion
Diagnostic Confirmation: Further testing with computer-
ized transaxial tomography (CTT) scans of the neck should Aplastic anemia is a disease resulting from failure of the
yield a more definite evaluation (Fig. 3). These scans are fre-
bone miirrow to produce adequate numbers of eiythrocytes,
quently used diagnostically because of their fine soft-tissue leukocytes, and thrombocytes. This disorder may be caused
discriininating capabilities. Although examination with oral by drags, chemicals, or viral agents that may directly or indi-
contrast medium is useful in determining esophageal versus rectly damage the bone m;uT0w. leading to pancytopenia. The
tracheal involvement. Patient A's CTT .scan was perfonned main causes of death from aplastic anemia iue hemonhage
with intravenous contrast because of her dysphagia. Figure ?>
and infection. Therefore, the goals of therapy iue manage-
shows soft-tissue fullness posterior to the trachea and withui ment and prevention of bleeding and infectious complica-
the retropharyngeal tissues. tions, pending bone manow reccwery.'
These patients generally require frequent transfusions of
Action and Therapy red cells and platelets. Due to the frequent transfusions and
the common need for parenteral therapies, a central venous
The initial appropriate intervention in a patient with soft- catheter may be indicated. Percutaneous catheters have been
tissue swelling and bleeding into the retropharyngeal space is incriminated as sources of infection and hematoma fonna-
to moniior the [xilient's airway patency. This is accom- tion.' AlteiUion to site selection for peivutaneous catheteri/a-
tion and platelet transfusion prior to catheterization may re- in the neck after two attempts had been made to cannulate the
may be more likely right internal jugular vein.' Genovesi and Simmons*" reported
duce complications.- Such complications
immunosuppressed patients.- on a patient who had been taking oral anticoagulants and de-
to occur in
The internal jugular vein may be the best route for central veloped bleeding into the retropharyngeal space after a sneez-
venous catheterization. If there is evidence of local bleeding, ing episode. For 3 days, the patient complained of sore throat
good hemostasis can usually be achieved by local compres- and dysphagia and subsequently required a tracheotomy be-
sion. This approach also avoids the pleura and subclavian ar- cause of sudden difficulty breathing.^
The retropharyngeal space lies between the pharynx and
teries, and the right internal jugular vein has an anatomically
As a consequence, this cervical spine and allows the pharynx to move during swal-
direct pathway into the right atrium.
lowing.' Bleeding into and subsequent hematoma formation
site also has a lower risk of pneumothorax and hemothorax.""*
Two previous case reports of upper airway obstruction within the retropharyngeal space can occur easily. Caregivers
secondary to abnormal coagulopathies have been published. must have knowledge of various emergency airway tech-
Knoblanche' reported complications from intemal-jugular- niques to prevent life-threatening emergencies caused by
vein cannulation that precipitated the requirement for endo- masses in this space. Endotracheal intubation via the oral or
hematoma nasal route may be facilitated with the use of a fiberoptic
tracheal intubation. One patient developed a large
1055
RESPIRATORY CARE • NOVEMBER '94 Vol 39 No 1
1
bronchoscope. In circumstances in which laryngoscopy is not airway. When positioned properly, the mouth and nasal cavi-
successful, cricothyroidotomy, tracheotomy, and translaryn- ties are sealed, a pharyngeal balloon blocks the oropharynx,
geal intubation may be successful. An esophageal-tracheal and a distal cuff blocks the esophagus. This helps ensure ade-
tube (Combitube. Sheridan Catheter Corp, Argyle NY) may quate ventilation and protection from pulmonary aspiration
'-
be used to stabilize the airway until conditions are better con- of gastric contents.**
trolled and a more definitive method of airway protection can We present just a few of the techniques that may be em-
be established. ployed in managing difficult airways due to obstruction by
The main objective in management of upper airway ob- hematoma. It is important for health-care professionals to
struction is to gain control of the airway by bypassing the ob- recognize impending airway emergencies and to act quickly.
struction.* Oral intubation by laryngoscopy is the most fre- Retropharyngeal hematomas are not uncommon occurrences
quently employed method. This technique allows the clini- in trauma patients with cervical or spinal injuries. The cases
cian to visualize the upper airway structures; however, it also we present are unusual because the threat to the patient's air-
causes the greatest stimulation of airway reflexes. The use of way was secondary to a bleeding disorder. The outcome for
intravenous sedation helps relieve the patient's anxiety and each patient was different, but careful attention to ensuring
maintains lower esophageal tone. Risks associated with oral airway patency was required and appropriate in both cases
endotracheal intubation apply to all patients and include po- for management of upper airway obstruction.
tions as a stent over which to guide the endotracheal tube CVMosby. 1990:110,115.
4. McGee WT, Mallory DL. Cannulation of the internal and external
through the mouth or nose. In addition, the bronchoscope pro-
jugular veins. In: Kirby RR. Taylor RW. eds. Problems in critical
vides improved visualization of upper airway structures, and
care: vascular cannulation. Philadelphia: JB Lippincott,
may help prevent local tissue damage.**' However, intubation 1988:221,223.
using fiberoptic bronchoscopy is not always an option due to 5. Knoblanche GE. Respiratory obstruction due to haematoma fol-
cause landmarks may be distorted due to the hematoma and ryngeal hematoma following cervical spine injury. J Spinal Disord
1991;4(3):264-269.
swelling. There is also a risk of development of further hemor-
8. Barratt GE, Coulthard SW. Upper airway obsUTJCtion: diagnosis
rhage, incorrect placement of tracheotomy, pneumothorax,
and management options. Contemp Anesth Pract 1987:9:73-96.
and subcutaneous emphysema.** However these techniques are 9. Benumof JL. Management of the difficult adult airway.
recommended as adjuncts for emergency airway management. Anesthesiology 1 99 1 :75( 6): 1 087- 1 1 1 0.
Translaryngeal intubation is a retrograde technique ac- 10. Somerson SJ, Sicilia MR. AANA journal course: update for nur.se
wire ends are pulled tightly, and an endotracheal tube is guid- Genioglossus hemorrhage after blunt facial U-auma. Ann Emerg
Lung Function: Assessment and Application pointing part was the superficial way that to summarize the te,sL Although some of the fig-
in Medicine, 5th edition, by JE Cotes DM DSc. flow-volume and volume-time issues were ures are good, others are difficult to interpret
Hardcover, illustrated, 768 pages. Oxford: covered in only 2 pages of a chapter that is 50 In summary, this is the fifth edition of a clas-
Blackwell Scientific Publications, 1993. pages long. Peak flow is given 1 paragraph, sic book on lung function, but it lack-s a certain
$135.00. hardly in line with its current importance, degree of polish. At best, this is a better than av-
when work of breathing got 2 pages and a fig- erage book on lung physiology. Although the
This book purports to describe "the res- ure! Chapter 6 is a description of the practical intended audience Ls wide, 1 think that only
piratory function of the lungs in a variety of measurement of lung mechanics and begins physiologists and pulmonary specialists will
circumstances and indicates how the func- with a table that grades the practical aspects of find it of much use. Given the cost of this book,
tion can be assessed." Thus, it is a combina- many lung function tests on a scale fix)m A to its purchase is probably only justified for the de-
tion pulmonary physiology textbook and D. 1 fail to see why such a subjective evalua- partment reference library.
technical manual for the performance of tion is useful and believe many of the grades
lung-fiinction testing. The author suggests are incoirect. Further, the degree of detail pro- Charles GIrvin PhD
that this book would be useful to scienUsts vided for many of the tests is inadequate. For Direaor
from a variety of disciplines. This is the fifth example, on Page 1 36, we are told to have the Pulmonary Physiology Unit
edition, and the author has attempted to in- subject practice the forced expiratory maneu- National Jewish Center for Immunology &
corporate the many changes in pulmonary ver and then "three technically satisfactory Respiratory Medicine
medicine since the fourth edition ( 1979). blows are recorded." What happens if you Denver, Colorado
The book is organized into 17 chapters. The don't get three? How many do you maximal-
first 4 chapters deal primarily with the topics of ly do? (Answer no more than eight). What is
historical perspective and terminology, equip- meant by satisfactory? The start and end of
ment, and technical issues. In general, the treat- test are not adequately explained. No explana- Snoring and Obstructive Sleep Apnea, 2nd
ment is adequate but disappointing in its lack of tion of back extrapolation is provided, and I edition, by David NF Fairbanks MD and Shiro
synthesis and failure to establish a perspective could not find the term in the index. The Fujita MD. Hardcover, illustrated, 266 pages.
for topics to come. Some of the material seems Ttffeneau index (FEVi/TVC or SVC) is men- New Yoifc Raven Press, 1994. $72.00.
dated — eg, the relative space given to old-fash- tioned, but why some clinical scientists think
ioned strip-chart reconders (2 pages) compared this is a better index is never explained. On the Snoring and Obstructive Sleep Apnea is a
to computer data capture ( 1 paragraph). Many other hand, the discussion of bronchodilator
cond.se well-written review of a complex clini-
of the techniques described just are not used response is good. Again, however, there is a
cal disorder. Edited by two prominent stugeoas
anymore. curious lack of balance where great detail is
in the field provides an extensive review of
The next chapters (5-14) are paired — given to measuring pressure-volume curves
it
uvulopalatoplasty.
lung. Although the figures are interesting and tent of Chapter 10, the technical aspects of
the chapter has all the right subheadings, the diffusion capacity, is adequate, although I think those who deal with snoring and sleep
content seems superficial. For example, in de- again I find it short on specific detail.
apnea patients as a part of their practice will find
scribing the equal-pressure-point theory, it is Finally, I find the book well referenced but this book a helpftil and informative review. It is
important to clearly explain the concept of ui> the references are difficult to use. They are not easy to read, well edited, and worth including in
stream resistance using the analogy of the wa- found at the end of chapters but rather are col- your reference library.
terfall. This analogy was introduced, albeit lected at the end of the book. In Chapter 6, spe-
briefly, but without a clear example. The au- cific authors are referred to, but I could find no Timothy R ChappeD MD
thor also attempted to explain the choke references. Many of the tables and figures are Pulmonary Medicine
point/wave speed theory, but this was done in only marginally helpftil. In additioa many of the Medical Center of Piano
a confusing way. Perhaps the most disap- tables seem to serve no ital purpose other than Piano, Texas
opinion or interpretation of information— not standard practice or the Journal's recommendation. Authors of criticized
material will have the
opportunity lo reply in print. No anonymous letters can be published. Type letter double-spaced, mark it
"For Publication," and mail it to
Letters RE.SPIRATORY CARE Journal, 1 1030 Abies Lane, Dallas TX 75229-459.1.
Errors in August CPGs circuits after intervals greater than 5 days American Association for Respiratory
Pressure-Limited. Time-Cycled Mechanical practitioners might read one or both of the geal mbe. RespirCare iyy4;.W(8):8l7-823.
Ventilation' states in Section 13.1 "The pediatric Guidelines without referring to the American Association for Respiratory Cai^.
"The Clinical Practice Guideline: Ventilator taking the following steps to minimize the
Circuit Changes . . . suggests that use peri- Stephen M Pieca MD 'damage': ( 1 ) publication of Dr Picca" s let-
ods < 5 days are acceptable when the humid- Nassau County Medical Center ter: (2) publication of a notice of Correction
ifying device is other than an aerosol genera- East Meadow. New York in this issue of the Journal: and (3) correc-
tor." tion of Clinical Practice Guideline reprints.
Respiratory Care
Open Forum Abstracts
F'^ '
Table 1
Index
: 1
infancy
infonis with respiratory distress syndrome (RDS);
rehospitalization 7%, pneumonia 7%, upper
GA:32±2 4 SDwks,BW: 773+628 SDg.
I
respiratory infection 44%, otitis media 20%,
Group II consisted of 8 infants with RDS who
1
wheezing 29%, and reactive airway disease also developed BPD GA 27+ 8 SD wks,1
54% The mean values of pulmonary function at BW:889±332 SD g Group was tested at
I
term and at 9 months corrected age (CA) are discharge or term post conceptual age (PCA)
shown with their percentile rank based on 36±2.4 SD wks aher a hospital stay of 4 wks.
healthy non-ventilated very low birthweight Group II was tested ol discharge or term PCA
(VLBW) infants (n=42,BW: 1242+213 SDg, 40± ,8 SD wks aher o hospital stoy of
1 3 wks. 1
adversely affected ii
Carlsbad. California.
therapy rnay i
have administered I
zed bronchodi
mspi rat ion manua I the Bird Mark
coordinated each t M.th the manual
the stalu
"^
Compare Unl-Vent to any other portable
RESENTING ventilator and you will quickly see why
the Model 750 a class by
THE FIRST is in Itself/
PORTABLE
l/ENTILATOR
THAT
DOESNT \
HAVE TO
APOLOGIZE
FOR BEING
PORTABLE!
Blender
CTRL --^
Formore Information on the Uni-Vent^'^ Model 750, or the name of your local Representative, call Impact today'
IMPACT Instrumentation, Inc., 27 Fairfield Place, P.O. Box 508, West Caldwell, NJ 07006 1-800/969-0750
Circle 96 on reader service card
Visit AARC Qgoth 1 325 in Las Vegas
Sooner or later
weaiiiig liiiii off the vent.
office at +852.529.0363.)
NELLCOR
NELLCOR jrul ULTRA CAI' m- lr.nli'marks ul Nt^lknr Iniorporatoil.
© Ni-llmr Iruorporntfil I'I'M, All rlRhls rescrvi-d.
"lungs" Mean VT and SD values were performing back pressure studies to evaluate
resistive pressure through vatves Differences
calculated Differences among the four methods
were evaluated using ANOVA p < 05 was among the three brands were evaluated using
considered significant RESULTS The mean ANOVA p < 05 was considered significant
VT and SD each method of ventilation m L
tor RESULTS At a flow of 50 Umin the mean and
was as M-M 99 i 26, KOL 25 t
follows SD inspiratory back pressures in cm H;0
Oil. MICRO 75 + 22 and RCK 64 + 15 produced by the devices were 7 22 ± 12.
There was a significant difference between the 16,70 1 1.17 and 2 15 lO 15 for KOL, MICRO
volumes obtained among the four methods of and RCK respectively The mean and SD
(ANOVA, p < 001) and significant
ventilation resistance in cm H^O/Usec was 8 66 i 15,
differenceswere found for each paired 20.04 ± 1 41 and 2 58 + 18 for KOL, MICRO
companson (Scheffe. p < 05) and RCK respectively There was a significant
CONCLUSIONS Only M-M ventilation resulted difference among the mean values for each
in an average VT delivery of at least 0.80 L as brand tested at 50 Umin (ANOVA, p < 001)
recommended by the AHA for rescue breathing and significant differences were found for each
paired companson (Scheffe, p < 05)
CONCLUSIONS The resistance of some of
these vatves may be considered excessive and
only one. RCK, met the ISO standard of back
pressure < 5 cm H,0 at 50 L/min
te DAMR Each DAMR was tested on a differeni da were manually ventilated with a disposable SIB by a
ossiblc effect of hand fatigue Airway pressure data member of the ED suff {RN, resident. MD. RRT) A
electronic pressure transducer (Pncumogaid 1230^
disposable vanablc onficc pncumotachomclcr and
fi
1068
To CREATE AN EASY-TO-USE, PATIENT-FRIEND
PEAK FLOW METER,
WE CONSULTED A VUvletu OF PRODUCT DESIGNERS.
,^
For more information contact your Baxter sales rep or call 1-800-933-0303.
I
The PEAK peak flow ed trademark ot MultiSPIRO, Inc
OXYLITE-mini
small cylinder provided with
the complete systems. All of the
OXYLITE units are also available
with the new, state of the art
cwnD
THERAPEUTICS
system illustrated lasts a 2 1/m OXYMATIC -2400 conserver 800-423-8870
Visit AARC Booth 1050 in Las Vegas Circle 117 on reader service card
1
TRU^ZONE
Logarithmic Scale
Simplifies reading of Peak Expiratory Flow Rate (PEFR)
One unit satisfies the standards for both children and adults
Cost Effective
One peak flow meter for all users
ColorZone^M Tapes
True zones as suggested by the NAEP
TruZone™ PFM
Actual zones, not end points, are easily identified shown actual size
Internal Indicator
Reliable and accurate readings -
indicator is enclosed and tamper proof
compliance
Fits in pocket or purse The TruZone™ PFM meets all NAEP standards.
monaghan ^^i^fi^'
Peal<
Sponsors of AARC'S
Performance USA Program
Circle 122 on reader service card
Visit AARC Booth 813 in Las Vegas
Open Forum ABSTRACTS RESPIRATORY CARE • NOVEMBER '94 Vol 39 No
VALIDATION OF A NOMOGRAM FOR EFFECT OF PEEP IN CONGENITAL THE CORRELATION BETWEEN FLOW RATE. ET
CONTROLLING C02 DF.LIVERY DURING DIAPHRAGMATIC HERNIA TUBE DIAMETER. POsnTVE PRESSURE. AND TIDAL
MECHANICAL VENTILATION VOLUME IN A NEONATAL MECHANICAL TEST
l.vnneK Bower RRT John H. Arnold MD. .
LUNG Lon J Wen BS. CRCP. Lisa J Schuli BS. CROP
Susan Anderson. RRT. Roben L, Chalbum.RRT. John E. Thompson RRT. Patrice Benjamin Rcaptratory CaxK Services. Mcrib^art MolicaJ Center -
Rainbow Babies Hospital, Cleveland. OH. RRT, and Jay M. Wilson MD Fargo. Nonh Dakota
Children's Hospital • Boston, MA Inlnxjuction The cflcct of flow rate on tidal volume
Posloperauve cardiac pediatric patients are
dclivcied. thiDugh very small mfani endotracheal ttjbca. has
sometimes given C02 to manipulate pulmonary Introduction: The high risk congenital not been ajmplctcly studied Hypothesis We hypothesized
vascular resistance, thus affecting pulmonary vs diaphragmatic hernia (CDH) infant that an mcrcaae in flow. Ousjugh very small cndouachcal
pcnpheral blood flow (Ann Thorac Surg continues to be a challenge to ventilate. would dcLvcr a larger uda] volume Evaluation
lut^cs.
to assess the agreement of nomogram values with physiologic dead.space (VDAT). PaCOo and TTL sunulator set with an mfaot lung (compLa/Kc of 005
Ucm/H:0. and a lesisUincc of 50 cm H20/tJs) were used
measured gas concentration values. METHODS: Pa02 in CDH infants. Methods: m this study Positive pressures nuigcd from PIPs of 10 to
Two Bu-d 02 blenders were connected in senes. The Patients were sedated, paralyzed, and 30 cm H20, and PEEPs of 2. 4. and 6 cm H20 Rows
first (o) was supplied by C02 and air and fed uito ventilated in the pressure control mode on tested WTie 4, 6. 8. and 10 1pm Tidal volume was measur-
the second blender (P), also supplied by 02. ed usmg Pnucmoview software from a TTL. cahbmled to
the Servo 900C. Standard ventilator
manufacluie's tecommendauons Mallinckrodt brand Lt
setungs were a PIP/PEEP of 30/5 cm H2O
t
Predicted values of FiC02 and Fi02 were compared
sizes lungcd from 2 5 lo 4 ID. each 13 cm length m
to values measured with a Daiex C02 analyzer and and a rale of .10 breaths/min. Cdyn, VDrVT Evaluation Results The results revealed that once the
MiniOX 02 analyzer. The MiniOX was used as a ratios, and arterial blood gases were How to generate desired PIP was met. further
clinical rather than a laboratory standard. Analyzers obtained during routine separations from the
were calibrated with standard gases. Blender ECMO circuit. PEEP levels were lowered
cahbrations were verified with an 02 analyzer from
to 2 cmH20 while maintaining the same
a metabolic carl. Usmg nomogram-denved blender peak inspiratory pressure. Measurements
settings. 8 levels of 02 (20-75%) and 8 levels of were then repeated. Results: Seventeen
C02 (1-9%). inrandom order, were analyzed in CDH infants who required ECMO were
triplicate. The mean and standard deviation of evaluated. There was a significant
differences (predicted-measured values) were used improvement in Cdyn (p=.006), VD/VT
esumaie upper and lower agreement
10 limits.
(p=.011). and Vt/kg (p<.001) when
System equations: decreasing the PEEP from 5 cmH20 to 2
cmH20. The PaCOi also significantly
improved on a lower PEEP (p=.02),
--='4-'^^^S^-^^-- hovever, there was no significant difference
in the Pa02. Discussion: We conclude
_ ^, (l-ppO2)(Q.85FaO2-0.18)
nuu-:-!.^/ , that both VOWT and Cdyn in the CDH
o.82-0.15Fa02 infant significantly improves on low levels
of PEEP. Concurrently, the lowering of the
RESULTS: The agreement interval (mean mean airway pressure does not adversely
difference ± 2 standard deviauons) for predicted affect the Pa02. This suggests that PEEP
minus measured FiC02 was 0, 1 ± 0,8 %. For Fi02 levels greater than 2 cmH20 worsens
near 21% agreement was -0.7 ± 0.2 %. For higher physiologic deadspace and compliance
Fi02s the agreement interval was 4.1 ± 2.2 %. during trials off of potentially ECMO
CONCLUSIONS: The agreement intervals for altering the clinical assessment. Future
FiC02 and Fi02 were clinically acceptable. The studies will be directed to determine whether
nomogram should be an efficient bedside tool for it is the anatomic and/or alveolar deadspace
the clinician, expediting system set-up and changes. that increases with higher PEEP levels.
Respiratory dysfunction after surgery for MechanicAl venlilnlion wilh an open chesl occurs
ronf>eniUil heart disease in children can lead to daily in Ihe oprralinf; room for children who
signincanl morbidity and mortality. The effects of undergo repair of complex cardiac anomalies. The
cardiopulmonary bypass (CPB) on respiratory efTect of open versus closed chest mechanical
mechanics have be«n difncull to obtain in the ventilalion on respiralnry mechanics ha>e previously
operating room, until recently. Portable, on-line been dirTicuIl to ohtain in this population. Bedside
devices are now available which allow precise devices are now available which allow precise
measurement of lunf; mechanics. This study measurement o( lung mechanics. This study
investigated the efTect of CPH on airway resistance investigated the effect of intra-operative open versus
and dynamic compliance using a mobile closed chest ventilation on airway resistance and
respiratory mechanics device. MKTIIOn: 23 dynamic compliance using a mobile respiratory
children, who underwent CPB fur surgical mechanics device. MF.TIIOD.S: 16 children who
correction of congenital heart disease were underwent surgical correction of congenital heart
studied. Ages ranged from 1 week to 48 months. disease were studied intraoperatively. Ages ranged
Body weights ranged from 2.9 to 2J.9 Kgs. A from I to .10 months. Body weights ranged from
stand akine respiratory mechanics monitor 2.9 to 14.8 Kgs. A stand alone respiratory
(Ventrak, Novametrix Medical Systems Inc., mechanics monilnr (Ventrak, Novametriv Medical
Wallingford, CT) was placed in-line with a
.Systems Inc.. Wallingford, CII was placed in line
conventional anesthesia ventilator (Draeger IIB, with a conventional anesthesia ventilator (Oraeger
Oraeger, Inc., Chantilly. VA| in the operating
IIB, Draeger, Inc.. Chantilly, VA). Airway
room. PKKP was held constant at 4 cm 1120.
reslstanrr (Bawl and dynamic compliance (Cdyn)
delivered tidal volume wa.s adjusted to ml/kg,
Iti
were measured immediately before aod after mediao
before and after CPB. No changes were made in
slernnloiny. I'Kl.l" was held constant at 4 cm 1120
Row had an open
rate or pattern. All patients
and delivered tidal volume was adjusted to 10
chest via median sternotomy. Airway resistance
ml/kg. No chaoges were made in now rale or
<Raw) and dynamic compliance (Cdyn) were
pattern. Measurements were averaged over a five
measured immediately before and after CPB.
minute study period. ResulLs are listed as the mean
Values were averaged over a five minute study
value +/. standard deviation. .Student's paired t-
peri(»d. Results are listed as the mean value +/
lesLs were used to assess intra-group difference.
standard deviation. Student's paired l-lesi was
A p < O.O.'i was considered signifu-anl. K l-:,Sll| ,TS:
used to assess inlra-grniip differences. A p-value
Mean dynamic compliance and airway resistance
of < 0.05' was considered tignificanl. Ri-SULTS:
with chest closed were .S.2 inl/cm 1120 and 147
In the prt^hypass period, mean dyn.
Dynamic compliance increas.,d 17% wilh
ml/l./sec.
™iplia and a I ml/cm
the chest open (p= .020)-. change* in airway
Il2()and l.t? ml/1120/1. respectively. After
resistance were not signincanl (p = .tS0721.
,
no other MDi
spacer delivers
like ace:
Thanks, DHD."
joe Nicoletti, RRT,
Coordinator of
Respiratory TJierapi/
Enhancer,
vou're assured
of fast,
1'800'847'8000.
ngcl;
All Pts with Pts with Pts with
Age
months
ALP is represented in your area by Automatic Liquid Padcaging, Inc.
the leading Respiratory/Anesthesia
BOTTLES ARE Healthcare Products Division
A SNAP TO
Dealers. 2200 West Lake Shore Drive
OPEN (no
Woodstock, Illinois 60098 U.S.A.
puncture pins) Tel. (815)338-9500
) 1993 AUTOMATIC LIQUID PACKAGING, INC. Tel. (800) 638-9778
Fax (815)338-5504
Circle 113 on reader service card
Visit AARC Booths 137 and 139 in Las Vegas
1
compared to 2 h for those using the CC HLAG method range from 1.0 to
using the classification summary by group
-0.5 (mean = 0,18), The Pearson r was 0,80 membership for the graduates (jack -knifed
Ccrtincalion Tair (129 h loial)
where Y intercept: F(X) = 0.83X + 0.02. The
CONCLUSION llic Certifiiation Tair proved to cross-validation or percentage correctly
power of r is >0.99 and the standard error of was accurate at a 94 6% level.
be a valuable tool in alUnving all RCP's to classified)
estimate is 0.18, Conclusions: There was strong
complete their clicckofTs for the year in 2 h. CONCLUSIONS: For the programs
positive correlation between the PB method and
compared to 3 5 h with the follow \ip mcthoil studied, the five correlated factors could
the HLAG method. Since the CC calculated by
be used in the recruiting of individuals
By demonstrating clinical skills In a mock
the PB method is provided during test scoring, it
The ex post
clinical setting, it ensures eonsisiency in the into the uaining programs.
IS Ihe preferred method. The CC with the HLAG
level of clinical prottcicncy demonstrated by the facto design of this study precludes
method is more time-consuming but it is a
Respiratory Care Department, as well as a cost extrapolation of the finding into other
valuable alternative if equipment is not available.
savings programs. of.94-009R
" OF-94-006R
between students at the two sites recetved as in-patients, but opportunities exist for respvtndenLs, 93% nxjuia' students lo rt^d
RESULTS Analyses revealed that there improvement The use of pnnted handouts could researxh, 26% prxwide a formal to evaluate
were neither practical nor statistically enhance the pabenfs retenbon of instructions,
it, CONCLUSIONS: Formal n^'anh courses
signiHcant differences in the pertormance of given the age of our patient population (mean age
are largely n-slncti\l lo BS programs. But,
the two student groups EXPERIENCE: The 60 5 years, range 19-89 years) Greater emphasis
authors have used Inleradlve should also be placed upon the importance of
K>th AD
and BS progran\s, in general,
teleconference inslfuctlon in the training of regular PEFR monrtonng These results nxjum' students lo road reseanh and leach
respiratory care practitioners for two demonstrate the valuable role RCPs can play m them lo interprx'l it. LIMITAHONS:
consecutive years CONCLUSION: patient education, and the importance of follow-up Ri-spt>n,se rale (64%) may have influencisj
Interactive telecommunication technology is assessment of petient oducation programs post n-sulls; a misworded REQ item n^ay have
an effective means of assunng the discharge Anecdotely. individuals contacted were taus**d Its mis interpretation.
pleased with the foltow-up call by respiratory care
equivalence of instmctlonal outcomes
potentially enhancing pattent-institotion relations
among multiple traming sites
OF-g-iioi
.
international confirmation
of quality procedures.
Bear
Jircle 1
sit
15 on reader service card
AARC Booth 1119 in Las Vegas £ BEAR' 1000
1
1082
Learn the
Blood Institute has made available S^le copies are free of charge
"How You Can Help Patients St; by calling oriA^riting:
Smoking: Opportunities for
OF-94-C
DRUG DELIVERY BY MEDK ATIUN NEBULl/ERS EXHALATION RESISTANCE WHEN USING THE EFFECT Ol- \ lUMIOm' AND SIMULATED PA-
AEROSOL INHALED Sharon Pewler. RRT Dear Hess, .
AEROSOL CHARGING ADAPTER WITH ADULTS TIENT EFR^RTON AEROSOL DEPOSITION
S- David Piper. P.E. Vorlran Medical
Technology.
MEd. RRT. Pums Wiltiams. BS. RRT. Daniel Fisher. BS. .
amount of drug delivered by a nebulizer to the mouthpiece continuous flow ventilation system. The ACA has pre- Stritch School of Mtxiicine, Hines IL
of the device for a specific breathing pattern (J Aerosol viosly been used with neonates but may increase
Med I99I.4 229) We evaluated uf»-ojo/ inAo/et/ from 17 exhalation resistance when used with aduHs Melhod:
Heated humidificabon wath mechanical ventila-
commercially available nebulizers at 3 flows and 3 solution was perlormed using a Michigan
In-vrlro testing
volumes METHOD The nebulizers were evaluated at Instmments Venl Aid TTL artificial lung, and a Purilan
bon has been shown to decrease delivery of
flows of 6. 8. and 10 L/min and at solution volumes of 3. 4,
Bennett 7200A ventilator with Mode 50 FLOW-BY. aerosol to the lun^ with STnall volume nebulizer.
and 5 mL Three of each nebulizer type were evaluated at
Pressures were measured proximal lo the ETT and at We developed a bench mtxiel to detemTii>e the
each flow and solution volume The solution contained OS the PW using two Dwyer Magnehelic pressure gauges changes in relabve humidity (RH) and
effect of
mL of 5% albuterol solution (2 5 mg) A double-sided test
calibrated at and 10 cm HjO. AuloPEEP indicat- spontaneous effort cffi aerosol delivery to the
lung with lift bar was used to simulate spontaneous ed by the ventilalor{VENT} was also recorded FLOW- lower respiratory tract using metered dose inhalCT
breathmg One side of the test lung was attached to a BY and MiniHEART flows were maintained at 8 and 2
Punian-Bennetl 7200 (rate 2/min. Vj 7 L. sine wave (MDl) in intubated, mechanically ventilated adult
1
L/min respectively- IE ratio was mamlained at 1 2.
(low 30 L/minl, and the other side was attached to the pabents. METHODS: A model consisting of an
compliance at 05 Ucm-HjO. PEEP was set to
nebulizer. Aerosol inhaled was evaluated using a
cm-H20. and a 7 5 mm ETT was used for all lesls
endobacheal hibe (8.0 mm
ID x 26 cm) in a plasbc
modification of a previously described method (Respir
Control values were established by removing Ihe ACA. model of a trachea (16 mm
ID x 100 mm) and
Care 1992.37 1233) The mouthpiece of the nebulizer was
setting FLOW-BY to 10 L/min and repeating Ihe tests. major bronchi (11 mm
ID x 40 mm) was attached
replaced with a slcpdown adapter, and cotton wadding was
The parameters tested were: to a two aimpartment test lung ainnected in par-
placed into the adaptor to trap aerosol The nebulizer was BPM
Respiratory Rate(RR) 14, 24. 30 allel by a metal bar. Inflabtm of one compartment
operated until nebulizalion was complete Albuterol was mL
Tidal Volume(TV) 600. 600. 1000. 1200 simulated spontaneous breaths in the other com-
then extracted from the cotton using 20 mL of 9% saline
The setup included a Purilan Bennen baclena
in-vitro
partmenL A ventilator with wick humidifier was
with gentle agitation by vortex The resulting solution was
filler, humidifier and water traps, all measurements
centnfuged at 5000 G for 10 mm to remove all cotton used with a chamber type MDI adapter
were repeated 3 times in separate runs Results: There
fibers, and absorbance was measured ai 278 nm (Bcckman ( AenziVent) placed in the inspiratory limb 1 5 cm
CA) A
was no measured autoPEEP lor combinations of
DU Spectrophoiomclcr. Irvine. standard curve for proximal to the ET. Twelve puffs of albuterol MDI
parameters which included RR's of 14 and 24 BPM.
albuterol was constructed from the absorbance of serial
AutoPEEP for RR's of 30 BPM are listed below ( lOHO pg) were given at the begirtning of inspira-
dilutions of a stock solution of 005 mg/mL prepared from
(meanistandard deviation): tion during a) a>ntrol, b) pressure support (PS) of
powdered drug (Sigma. St. Louis. MO) The amount of
TV (mL) 600 800 1000 1200 10 cmH^O and c) spontaneous breaths
drug extracted from the cotton was determined from the
ETTCcmHjO) 0±0 910 1 2 7±0 1 3 8±0 1 Experiments were performed under dry (27° C, <
standard curve The percent of the albuterol placed into the
nebulizer cup that was delivered to the conon wadding PW(cmH20) 0±0 0*0 1,1±0 1 2.1±0,1 10 %
RH) and wet (35° C, llXf'/o RH) conditions
VENT{cmH20) a±0 0±0 a±0 1 OiO
{aerosol inhaled) was calculated Statistical analysis (n=3). Albuterol depositionon filters placed at the
consisted of ANOVA RESULTS Aerosol mhaled v^^ AutoPEEP for the control tests at 30 BPM were:
ends of the main bronchi was measurt?d by spec^
significantly less with a flow of 10 L/min (20 3±6 8% for 6 TV (mL) 600 800 1000 1200
trDpho-tometry(246nm). RESULTS: Under wet
ETTCcmHjO) 0.0±0 0.a±0 O.OIO 1 0±0 1
Umin. 19 6*6 4 forSUmin. 18 1±6 I^/ofor lOL/min.
00±0 0±0 conditions, delivery of albuterol was greater with
P=0 01 Aerosol inhaled was also significanlly less with a
) PW(cmH20) 0±0 1,0±0.1
VENT(cmH20) 0±0 a±0 0,0±0 spontaneous breaths (220 ± 21|ig) tfwi cMitrol
smaller solution volume (17 5±5 8%for3mL, I9 8±6 6% 0.0+0
for 4 mL. and 20 7±6 7% for 5 mL. P-0 000 ) There was 1 Experience: S David Piper, P E. is a Regis (182±21pg)orPS10(172±27pg)(p<0.01) Tlie
a significant difference between nebulizers in aerosol Professional Engir T the State of California, has fraction of albuterol delivered to the lower respira-
.nAo/^<^(P<OOOI) CONCLUSIONS Overall, about 20% been developing and conducting research on tory tract under dry conditions (30 - 35%) was
cup was
or less of the albuterol placed into the nebulizer respiratory products lor over 4 years, and has received greater than wet ( 17 - 20"/..) in all modes (p<0.005).
delivered to the mouthpiece of the device Although patents tor nebulizer and aerosol delivery lechnologies- CONCLUSION: Heated humidity reduced deliv-
aerosol inhaled v^as affected by flow, solution volume, and Otlo G Raabe. Ph D. is a Professor of Environmental ery of albuterol in this model of a ventilated sjxin-
nebulizer brand, the clinical importance of these Engineering at the University of California Conclusion:
taneously breathing patient
difTcrcnccs remains to be determined Wc believe that the The ACA may be used with adults under ordinary
concept of aerosol inhaled is a useful method to respiralory settings at RR"s up to 30 BPM with minimal
characterize aerosol delivery systems which autoPEEP Supported by V A Research Service
autoPEEP, For Ihose conditions in
(supported in pan by Puritan -Bennett Hudson RCI, may not accurately indicate
exists, the ventilator
Marqucst, Professional Medical, SIMS, Inspired Medical)
autoPEEP at the ETT.
OF-94-080 OF-94-140 OF-S
IMPACT OF HUMIDITY ON RESPIR- EVALUATION OF THREE NEBUUZERS FOR FFECTIVENESS OF METERED-DOSE INHALER
ERSUS NEBULIZED DELIVERY OF ALBUTEROL IN
ABLE VOLUME OF MEDICATION DE- LENGTH OF NEBULIZATION TIME NFANTS WITH BRONCHIOLITIS. A
LIVERED VIA VENTILATOR William M Heulitt MD. M Anders RRT,
W. Quinn RPFT RRT Ochsner Stephen F. Wehrman RRT. Warren Sakamoto CRH, G Lowe RRT P Andei .
Ark
Foundation Hospital New Orleans, Wesley Caner CRTT, Anthony de Nectxhea CRTT
Louisiana. Previous reports have Kafiiolani Community College. Honolulu. Hawaii
suggested that continuous flow
nebulization is more successful Introduclion: The length of time ii lakes a small
in delivering medication when votume netxilizer to deliver a standard amount ol
the nebulizer is placed upstream sdubon affects total time spent performing this
from the patient wye. However, therapy and could impact on productivity. Previous
these same studies did not research try Hemstreet et al. published in an abstract
include a humidifier. I sought in Respiratory CareV olume 38, Number 1i suggests
to observe the impact of various
that nebulization beyond "sputter time' (the
humidif ication conditions on spasmodic release of aerosol at l5-30s without
respirable volume of medication visible release of aerosol) is unproducbve A review
delivered by a nebulizer in a
of five respiralory care textbooks suggests operating
ventilator circuit to a test
the nebulizer at six to eight liters per minute We
lung. Method: A Laser particle
compared the length of time it look three different
counter (PC) was adapted to the
brands ol nebulizers to reach 'sputter lime' at two
02 sensor port of a Michigan In-
different flow rates.
struments Training Test Lung
Hethod: Five Baxter •Airlile', Marquest Acorn II.
(TTL) so that a sample could be
and Satter Laboratories model #6911 nebulizers from
aspirated from the TTL into the
two lots were tested using a three ml unit dose of
PC. Three methods were tested
normal saline at six and eight tilers per minute
five times each, data being
respectively. An accurate Puntan Bennett air
collected after the system had
flowmeter was used lor the lesls.
run connected to a ventilator
Results: Results are shown in the table betow
with nebulizer running for three
minutes. Results were converted
from counts of various particle Average Nebulization Time {mm )
3)Nebulizer in VP with gas that saving two to three minutes per ireatmeni over
humidified to 34 C in a heated a busy shiH makes a diflerence in practitioner
wire circuit: .51(.02) productivity and ability to complete a workload in a
Respirable volume of medication timely manner.
delivered by the VP with dry gas Conclusion: Use ol a Mow rale ol eight UMin. a
was Significantly higher (p^.05 llme-eHicient nebulizer, and termination ol therapy
by ANOVA) than all other methods at the 'sputter time' could increase a practitioner's
t.-stfd. Conclusion: When using a produaive time Managers shoukJ evaluate the
nebulizer in the VP, bypassing delivery ol small volume nebulizer therapy lo
the humidifer can enhance maximize productivity.
medication delivery. „^_. OF -94 192
After 10 years of continuous improvement
liow come its face isn't prettier?
LIFECARE® protects patients with LIFECARE keeps the Interface the same, LIFECARE gives you, and your patients,
absolute state-of-tlie-art technology so it remains easy to use. the best service.
In the ten years we've been making the All these changes have been real benefits. Check with any of the thousands of physicians,
PLV®-100, we've made improvement after Nothing's been done for just cosmetic respiratory therapists, nurses or suppliers who
improvement to be sure we offer the most reasons, or to try to impress you with a new have experience with us and you will find that no
modern, effective portable volume ventilator product name. The interface and controls, one matches our reputation for service. Our
available. Features like a quieter, stronger proven in use for more than 10 years, remain clinicians and technical service staff are available
direct drive motor, A precision-ground ball the same. So, users get our new technology to you constantly, quickly— and locally— in 21
screw. More accurate tracking. More reliable without having to change to a new model. places across the USA. LIFECARE Asia-Pacific and
delivery of both greater and smaller volumes LIFECARE Europe provide high-level service in
than the competition. The PLV-100 has been, over 40 countries. For complete information
about the PLV-100 or our many other respiratory
and will be constantly updated to the highest
standards— yours.
LIFECARE products, please contact us. 1-800-669-9234
State-of-The-Art Technology
and Superior Service
LIFECARE INTERNATIONAL, INC. LIFECARE EUROPEGmbH LIFECARE Asia/Pacific Sales & Service Center
Lafayette. CO • USA HeiTSching • Germany Mongkok. Kowloon • Hong Kong
49/8152-93060 • FAX: 49/8152-930618 852/771-1886• FAX: 852/770-7557
800/669-9234 • 303/666-9234 • FAX: 303/666-0415
^
OF-94248
prevent Pneumotach.
The pre Vent Pneumotach snaps in and out of your For product literature, or to see the preVent
pulmonary function system in seconds, giving you Pneumotach's impact on a broad range of clinical
an unprecedented method for applications, including cardiopul-
MedGraphics.
©1991. Medical Graphics Cofpof^tion Cardiorespiratory Diagnostic Systems
Medical Graphics Corporation 350 Oak Grove Parkway Tel. (612) 484-4874
The World Leader in Cardiorespiratory Diagnostic Systems StPaul. MN 55127-8599 Fax (612) 484-8941
Commg M270 CO-oximetcr. Initially .more than 200 peak flowmeierWPFM) has gained increased acceptance i
the cntcria of a low Pa02 and high Sa02 (NAEP) has act uandards" lo which these meters should approximately 20-30% of the total lung volume. This ratio
Surpnsingly, these results were consislcnlly being adhere This study was designed to evaiuaie four of the of residual volume to total lung capacity is essenUally the
reported from chtical care patients. A total of newer PFM on the maikci. Personal Besi~(PBl Poekei same regardless of size. A retrospective analysis was
greater than were studied whose abg-CO or
40 pis
Pcak™lPPl The Peak™(Pl and Spu--o-rtow™tSFl. conducted on subjects tested at the University of Michigan
(21 Method Tarpel Hows of ATS wavefomi *24 were
rcsulls consistentlymet this critena AdJilional Pulmonary Laboratory dunng the year^ of 1991 through
produced using a cabbraicd waveform generator. Ten um
pu meeting Ihc above critena continued lo he 1 994 In reviewmg 4.5 2 subject1 tests the RV/TLC rauo
of each brand mcttr were tested ai four fkiw rates, each
included CO-oximetry is routinely performed on ranged from10% lo 80% with the greatest distnbution
flow was repealed five times Readings were taken by a
mixed-venous samples to obtain information necessary
^gleo rfor. Qdevic occumng between 30% and 40% All subject tests were
for cardiac profiles Common among patients were
combinations of one or more of 1) Tylenol cherry
nearest 5 L/M The data obi uicluded m this analysis regardless of their respective
to NAEP guidchnea lor ace respiratory status. The subject population mcluded 2.238
elixir 2) Toul Parenlcral Nutrition (TPN contaming
device vanability males and 2J.14 females, aged 17 to 94. height 51 uiches
greater than 10% lipids) via a tnple lumen catheter.
(31 Resulls
This investigation was undertaken to identify possible to 80 mcbes and weight 60 pounds to 465 pounds. The
target flow 125 6 L/M
causes of unusual mixcd-vcnous results.(2) We subject populauon was divided mto three broad catcgones
compared mixed-vcnous results of twenty-two control based on ethnic backgrounds: Black 634. Caucasian 3,806
patients receiving 650mg cherry Tylenol elixir &/or and Other 72- All fimcUonal residual capaciUes were
TPN via a triple lumen catheter A full spectral scan measured utilizing a Medical Graphics 1 085
on spectrophotometer was performed on Tylenol spiked largci flow 300.3 L/M Plethysmograph. All spirometnc determinations were
venous (in-vilro). and Tylenol mixcd-venous (in-vivol
measured utilizing the Med Soence 3000 and Medical
obtained via triple lumen catheter In a non-controlled
Graphics 1070 systems. Predicted values from Moms and
test, two blood donors mgcsted Tylenol elixir in a
dosage of 650mg Venous samples were dr^wn al 30mm, target flow 5005 L/M
Miller were utilized m the stiwly All procedures were
containing concentrations of 10%,20%. 30% & 53% 4.512 snidy populauon, 59 subject tests (1,3%) exhibited a
TPN (20%intralipid) tonomelcred to a po2 & pco2 of R V/TLC ratio of less than 20% Twenty one of the 59
40mmHg. were analyzed by CO-oximetry (3) The spectral target flow 719.1 L/M subject tests were clearly identified as Quality Assurance
scan of "normal" blood and that of Tylenol spiked issues while 10 subjects were the restilt of the vanancc of
blood (in vitro) overlay profiles are identical 2.7
the measurement at such small volumes. Only 3 subject
00
Spectral scan overlay profiles of Tylenol blood
(invivo) vs "normal" blood showed a shift in multiple
•• some dau off scale, scale ends at 720 L/M — tests
than
were
50%
identified as having a residual
which could not be attnbuted
volume of less
to methodology or
wave lengths of light above 625 00 nanometers A = ACCURACY = % difference trom target
V = INTER-DEVICE VARLABOJTY ^ % cocfSaert of var. quality assurance issues. This data is supportive of the
The CO-oxuncter results of TPN concentrations of 30%
R = REPRODUClBlLrrY - % wHhin 5% range or 10 L/M theory that the area of apposition establishes a boundary to
& 53% in venous blood were consistent with our initial
findrngs of an abnormally high 02Hb and S02 with a (4) EB, penenge Portable : PFM should be easy to read and which no greater reduction m volume can occur. Tbis
reliable enough lo ensure that readings obtained are useful enables the maintenance of a RV/TLC ratio equal to 20%
relatively low Po2 Results of non-controlled donor
Po2 30min rellecUons of current patient conditions. Many devices even the most severe restnctive ventilatory disease.
blood showed a short term drop in after in
used in the past have not been rcluble for home use
ingestion of Tylenol elixir (4) We concluded ihal
(5) Conclusions There are large variations in ihe products
.
A NEW INTERPRETATIVE PARAMETER FOR PATTERNS OF AIRWAY RESPONSIVENESS IN METHACHOLINE PROVOCATION TESTING ; ITS
SPIROMETRY PA Haiper, RFFT. MA True. RRT, ASTHMA PA Harper. RPFT, CM Foss. RRT. RPFT. SAFETY IN A DIVERSE PATIENT POPULATION,
RPFT. LB Graf. MSBME, FJ Martinez, MD Dept of MA True. RRT, RPFT. LB Graf. MS BME. FJ Martinez, LaskowtkiDlVlR.PFT- Unge PA MD,. Stoller JK
.
IntonaJ Medicine, Division of Pulmonary and CnticaJ MD. DcpL of Internal Medicme. Division of Pulmonary MD Kavuru
. M
M.D McCarthy K, RCP T The
,
CareMedicme UMMC, Ann Arbor, Michigan, USA and Cnucal Care Medicme Cleveland Clinic Foundalioo. Cleveland. Ohio. 44I9S.
UMMC. Ann Aibor, MI. USA
As an adjunct to ihe inlcrprelative process w. Melhacholinc Provocation testing (MPT) is a
lacorporaled the FEF25.75 ppd/FVC ppd ral Evidence To date, a positive response to methacholine challenge has and sensitive test that aids ihe chniaan in the
I
safe
suggests the FEF-,5.75 raiher than the FEV, is a more been viewed as an obstructive process characterized by
diagnosis of asthma 0\'cr the last two years we have
soisitive predictor of the presence of morphologic change changes m FVC. FEV, and sGaw The laboratory UMMC noted a significant increase m quenes from outside
Early pCTipheral airway dyslimction can be designates a positive response based on a decrease m
in the lung.
physicians and techmcians regarding patient selection
determined and easily identified utilizing the FEFiS-TS
FEVj >= 20% Although the seventy of obstiucUon has
for MPT and the safet> of the procedure We rc\iewed
been quantified in most laboratoncs based on a change m
ppd/FVC ppd. The dmumshed raUo when coupled with a
FEVj It has been noted that mdjviduals expencnong MPTs done over a 7 month penod m our outpatient
1
80% and good tcmuniil etTon {plateau of 2 sec. or more) 3% of flic baselme value An obstructive pattern is defined currently on or had been on bronchodilaiors (when
Lung volumes were measured utilizmg the Medical as one m which the FE V, /FVC raUo decreased by 4% or possible none x 24 hrs) pnor to testing
Graphics 1085 Plcthysmograph. Spwometnc more as a result of the testing procedure. We Average age was 48 years (range 7 - 90). 62%
dctcrmiiiauons were oblamcd from ihe McdScience 3000
retrospectively examined bronchoprovocation tests were females. 13 4% were mmonlies The lowest FVC
and Medical Graphics 1070 systems Because FEF2S.75 is performed m the pulmonary laboratory spanning a six year
al baseline was 1 23 L (40% of predicted), the lowest
period. The study populaUon was comprised of 1 1
a calculated value, early ccsaaUon of fiow will artificially FEVl at baselme was 96 L (37% of predicted) and
subjects, mcludmg 4 moles and 70 females, age
1 1 7-71
elevate the value thereby reducing the elTcctiveness of the the largest decrease in FEVl was 69% at 5 cumulative
yeBi3, height 61-73 mches,and weight 110-265 pounds
rmio In cases v4icre spirometry is Ihe only data available dose Ufuts (CDU's) There were no scr
Spirometry was performed utiltzmg the Medical Graphics
It IS difTicult to deuamme whether the reductions observed warranting physician intervention
1070 system and the MedScicnce 3000 system
m the FVC are the result of restnciive or obstrwUve
Calibration and spirometnc measurements were performed
disease alone or possibly a combination of both disease in accordance to current ATS guidclmcs Hyper-rcacuve Patienis si
entibca Reduction in FEF;5.75 values establish the responsiveness was associated with a dccbne in ihe FEVj
presence of airway obstruction, while mamlcnance of flow >a 20% Sixtv-thrce subjects wac classified a.s non-
rates with a reduction ui FVC are indicaLve of a reacuve and did not demonstrate a drop of 20% m the
ftamcuve process The FEF25.75 ppd/FVC ppd works FEV| Forty-eight subjects were classified as reactive and
well m dclectmg restrictive and modcralc- severe demonstrated a decline m the FEV, >= 20% Of flicsc 48
otMtnictive panems From spirometry alone we have subjects. 14(29%) preserved the FEVj/FVC raUo to
esUblished that a redo of 40% or less is an extremely
withm 3% of Ihe base line value This group with the
restncuve patlcm not only maintamed then FEV, /FVC lo
good predictor of an increase in RV with a normal or
withm 3% of their baseline, but also rruuniainod their
increased TLC, This usually denotes significant an
FEF25,75/FVCppd, thus exhibiting a prescrvaUon of the
trsppmg and suggests that an associated restrictive
Dow to volume relationship at low lung volumes (FEF25.
highly unlikely With a ratio of 20% or greaia
disorder is 1
disunguish lung volume utilising this ratio is negated in study of pulmonary mechamca dunng brondiopTOVocation
cues of lung resection, neuromuscular disease and poor testing moy be valuable in identifying the physiology of
this restnctive pattern
lexmmaJ effort.
OF 94-09 OF-94 1
Effectively weaning your patients
only delay a patient's recovery, but can Using the Peak Expiratory Flow software which automatically antici-
increase hospital costs. The Wave Monitor can help you determine if a pates the natural lung movement and
VM200 provides the information and filter is clogged, assess a response to a works with the patient to decrease
tools you need to make simple adjust- bronchodilator and observe changes in breathing effort and reduce stress. And
ments for superior patient weaning. compliance and resistance through working in any ventilator mode, our
and Ventilator ments on the ventilator you Call today for a complimentary
can lessen the chance for auto- demonstration of the Wave VM200,
For example, the Peak Inspira- PEEP and decrease work to number one for patient weaning.
flow versus patient flow demand recovery is om Predic- Post Office Box 2600, Newport Beach, CA 92658
800.451.3111 714.642.3910
and adjust accordingly tive Learning Logic Fax 714. 548. 3091
1 00 Hours Typical
Battery Life
1 8 Hours Optional
Memory
Printer Capability
Made in U.S.A.
Circle 152 on reader service card
Visit AARC Booths 401 and 403 in Las Vegas
1
IDENTIFICATION OF OLDER COMPARISON OF PEFR OF MINI WRJGHTS AND COMPARISON OF TRANSMITTED VS,
ASTHMATICS USING PEAK FLOW ASSESS PEAK FLOWMETERS TO VOLUME REFLECTIVE SP02 VALUES IN PATIENTS
LABILITY DISPLACEMENT SPIROMETRY Gayc BsdgweU RRT, WITH DIGITAL CLUBBING
Pat Wahcn BA RRT RPFT. Vanthiyi G»n MD.
ChUdrcn's Medical Center of Dallu, D&llu, Tcua 75235
DE Abbey. PhD. SF Knulscn. MD. PhD. R
Timnlhv A William,-! AS RRT.
Burchcttc. MS. WF McDonnell. MD. BA Pelcrs.
STUDY PURPOSE: To determine which brand of peak
. .
with esscntjally normal spirometry requires a SUBJECT Convenience sampling of 34 children ranging
careful history, and for objective conFir- in age from 4 yean to 17 years, all of whom have
, The I controversy as to
maiion, a bronchial challenge test which is diagnosed reactive airways disease.
whether transmitted (TPO) or reflective pulse
neither inexpensive nor without patient MATERIALS ATOD METHODS: Each patient
performed a pre and post bronchodilator flow-volume oximetry (RPO) is better in patients with digital
discomfort. Peak expiratory flow (PEF)
loop on a P K. Morgan Spiro-Qow volume displacement some caregivers have
lability based on multiple daily measures clubbing. For this reason,
with xpuDmclcr, as part of their outpatient visit. Each subject
may be helpful in identifying patients chosen RPO over TPO in pcdiatnc patients with
The Mini-
was then asked to perfonn the PEFR maneuver on the
increased bronchial reactivity.
digital clubbing This study analyzed the difference
Assess peak flowmeter (x 3 trials), and again on the Mini-
Wright Peak Row Meter was used to compare
Wright's (x 3 txiab) within thirty minulca of Oieu- post between these two methods in a population of
the lability index (PEF max - PEF mm / mean
bronchodtlator apiiomeUy measurement. Every other
PEF) with the National Heart. Lung, and Blood
pedialnc Cyslic Fibrosis patients METHODS: A
subject was asked to use the Mini-Wright's first with the
Institute(NHLBl) Respiratory Symptom Ncllcor N-IO pulse oximeter, verified with die PT-10
Assess second and vice vcraa. Using the student T-test
Questionnaire (RSQ) on self-reported asthma. statistical analysis program, the PEFR'i were compared
The RSQ was admmistercd to all subjects and as follows; Spirometer to Assess. Spirometer to Mini- index finger (DS-lOO transmitted sensor) and from
they were mstructed m
PEF measures. The Wright's, Assess to Mini-Wrighfs.
1cm above Uie right eyebrow (RS-10 refleclive
best of three PEF measures four limes a day RESULTS: PEFR's obtained from the Assess and Mini-
when compared
Wright's were both significantly different sensor. Nellcor Inc.. Hcyward. CA). Three samples
were recorded on a pre -printed diary and
consisted to the volume displacement spirometer (P = <0,05). were obliiined from each site. The patients were
returned after seven days. Subjects
PEFR's obtained from both peak flowmdera when placed into three groups according to the level of
of 1414 male and female non-Hispanic. White,
compared to each other were NOT significanUy different
non-smoking. California residents from an clubbing; control (Nil), mild (N = 19) and severe
(P= >0 05), Comparing the Aascss's values to the Mini-
Adventist Health Study cohort who have been (N =23) as described by Kendig (Disorders of
Wright's also revealed the following trend: The Assess Et. Al.
followed since 1977 with periodic assessment
PEFR was lower than the MW's 55% of the time.
value The Respiratory Tract in Small Children).
of RSQ. A total of 1251 subjects, 771 women The Assess PEFR value was higher Oian the MW's 32% RESULTS: Siudenfs T-Tcst was performed on all
(mean age 65,2 years, range 43-79) and 480 of the time, Tlie two peak flowmeters were actually equal
men (mean age 66.4 years, range 43-80), had 12% of the time
samples on each group TPO = 96.4 SD 75.
Control
accepuble PFTs and PEF measures and RSQ CONCLUSIONS: The Assess peak flowmeter and the RPO 97 2 SD TPO 96.3 SD .74. RPO
1,16- Mild
data. As determined by RSQ, there were 42 Mini-Wnghfs peak flowmeter do not accurately reflect
96 6SD 111 Severe TPO 92.6 SD .98. RPO 94.5
cases of definite asthma in women (5.6%) and PEFR when comftared to a volume displacement
SD 1 .56 The analysis of Oie variance between the
29 cases in men (5,9%). PEF lability in women spirometer. When meter are compared to each other, the
non-asthmatic readings are similar. An Assess peak flowmeter costs our mean differences of RPO and TPO between the
asthmatics was 14.5% (SD 8.0);
hospitalaround $15,00. whereas a Mini-Wright's peak groups was not sutislically significant. The control
women had an index of 10.9% ( SD 6.4); for
flowmeter costs us around $28,00, Both meters have a
men 14.9% (SD 7.5) and 10.0% (SD 5.8) group compared to mild and severe was P = 0.17 and
one year warranty issued by their manufacturer. We
respectively. These differences were P= 13 respectively. Comparison of mild to severe
conclude that it is more cost-effective using the Assess
significant by t-Test {women p=0.001; men p clubbing was P=0 09 CONCLUSIONS: A trend
peak flowmeter rather than the Mini-Wright's in certain of
<0.0001). The sensitivity of PEF lability for
populations suggested that more research be done to
It is
RPO values 2% higher than TPO was observed in the
detection of asthma in women
self-reported determine how each meter ages, how many meters
was 54.8% with a specificity of 69.4%; for
severe group. No statistical evidence that rcncclcd
patients lose, etc This would help understand overall cost
men. 58.6% and 73.4% respectively. These effectiveness. What is most important to remember, SjOZ values read higher than transmitted values in
results suggest that PEF lability can be a however, is that due to the trend of the peak flowmetcra patients with digital clubbing was found Although
simple, cost-effective method to assist in lo be equal only 12% of the time, it is recommended that
this study was limited by patient population, a larger
identifying and following older asthmatic the same brand of peak flowmeter be used when
multi-center study lo include CO-Oximctry may be
subjects. Funding provided by • gruU from the EPA measuring a patient's Peak Expiratory Flow Rate trends.
indicated nF-Od-nifil
OF 94-245 OF-94-24:
1 (W4
B first'jmcfoprocessor sessions. Our outstanding customer service, training,
contiolli-d vcjililator in ]%^fl&oUght it because it (.linical and technical support have helped many of
pro\ ided the ven latest in Ifflmarion technology. More you to log over a million hours on your 7200 fleets -
than a decade later, the 7200 Series Ventilatory System a testimonial to a quality product.
continues to set the standard. We were the first to offer Put all of this together and you'll agree that we're
flow triggering, respiratory mechanics, and PSOL still setting the standard. For more information,
breath delivery, keeping our promise of upgradeability. contact you local Puritan-Bennett representative or
We've added more than 20 new enhancements to the call 1-800-255-6773.
7200 and we're not stopping there.
- 1 - PURITAN
1
1 BENNETT.
SAFETY AND EFFICACY OF MINI- BHNHFITS A.SSfKlATED WITH A RESPIRATO MULTI-MODALITY PATIENT ASSESSMENT
BRONCHOALVEOLAR LAVAGE (MINI-BAL) RV CARi: A.SShSSMENT-TREATMENT PROTOCOL John Wright MBA BS RRT, Jerry
PERFORMED BY RESPIRATORY PRlXiRAM RESULTS OF A PILOT STUDY Gordon BS RRT, Henri Guidrv BS RRT UCLA .
THERAPISTS FOR THE DIAGNOSIS OF Kevin L.Shrjke MA RRT John E Scaggs BS RRT, . Medical Center, Los Angeles, CA
VENTILATOR-ASSOCIATED PNEUMONIA Kevin R England BA, Joseph Q Henkle MD.
(VAP). and Lanie E Eaglcton MD Introduction: Therapist Driven Protocols and
Kevin R. Bock. OS. RT Rodger Richards. CRTT;
:
brush (PSB). We evaluated the safety and cosl-ellci.li\c Ircalmenl pLuis with quality palieni oul-
common interventions is not available. The
accuracy of mini-BAL. performed by respiratory tomes, while maintaining appropnalc Multi-Modality Patrent Assessment Protocol
therapists using a telescoping catheter (BAL communications with physicians and nursing staff.
minimizes the chance of overlooking
Oath, Ballard Medical Products. Draper. Utah) as STUDY DEVELOPMENT & any one type of routine respiratory therapy
non-bronchoscopic technique suspected It also standardizes the
a for IMPLEMENTATION: The study's Task Force intervention.
VAP. Method: Definitions for the presence or developed protocols for oxygen ^erapy. aerosolized process of patient assessment,
absence of VAPwere modified from those taken medication therapy, volume expansion therapy, and increasing the consistency of clinical
from the ACCP 1992; 102:5535)and used
(Chest bronchial hygiene therapy using the American application as well as the recommendations
to delermme the individual test's performance Association for Respiratory Care's Clinical Practice by respiratory therapists to physicians. Method
charactenstics (i.e., sensitivity and specificity). Guidelines xs supporting documents. Meetings wen: A patient assessment form (screen) has been
Mmi-BAL was performed by instilling 25 cc of held with the orthopedic surgeons and nursing staff to used as the primary data collecting device at
sterile salme through the BAL-Cath with a synnge inform them of the key components of the pilot pro- the bedside for several years. The assessment
and then respiniting. Safety was assessed by gram. Ten patient evalualors were trained to assess results Vtfere then reviewed by a supervisor, A
comparing patient head rate, mean artenal patients ;ind implement treatment plans. EVALUA-
detailed algorithm (the Multi-Modality Patient
pressure, and artenal oxygen saturation (using TION METHODS: A reference book was established Assessment Protocol) was developed so that
pulse oximetry) at baseline to the worse value that contained the protocols and support material.
supervisors could evaluate the patient
obtamed dunng or withm 5 minutes of the Patient outcomes were evaluated using previously es-
procedure. Quantitative thresholds of > 10^ assessment according to the specific
tablished quality assurance plans. The length of stay,
cfu/mL were required for both the PSB and mim- steps of the algorithm Supervisors were
procedural volume, and cost data were collected.
BAL be supportive of a diagnosis of VAP. given a "pre-test" whereby they evaluated
to EVALUATION RESULTS: More than 50% of the
Results: No complications occurred in the the screens according to the existing
orders received dunng the pilot program were for
performance of 41 mini-BAL procedures. Safety "Respiratory Care Protocol." This allowed the patient technique. This group was then inserviced
profile data is shown in the table below. Twenty- c;u"e evalualnr the tlexibility to initiate one of the ap-
on the use of the algorithm [the Multi-Modality
four PSB samples were obtained for companson proved protocols if indicated. No changes in patient Patient Assesment Protocol). A "post-test" was
with 18 of these paired samples obtained in outcomes were noted and average length of shy then given to determine if consistency had
patients already receiving antibiotics. The remained unchanged during the pilot study compared improved with the use of the Multi-Modality
respective sensitivity and specificity values for
to the base period. Treatment volumes decreased, re- Patient Assessment Protocol. Consistency was
mini-BAL
these 24 paired samples are as follows: sulting in identified cost savings of $5.3 1 8 during the defined as the percentage of similar answers.
100%, 93%; PSB: 57%, 100%. Experience: Our study. Nurses and physicians supported protocol im- Accuracy was defined as the precise choice
experience suggests that respiratory therapists can plementation, and increased communication among of modality according to the protocol.
safely perform mim-BAL m mechanically
caregivers was documented. We believe that profes- Detrimental therapy was the term used to
ventilated patients. Conclu^iion: Future studies of sionalism of the RCPs was enhanced without comprtv describe assessments that could potentially
nonbroDchoscopic performed
techniques, by mising the ultimate decision- making re.sponsibilities
respiratory therapists, to sample lower airway
harm the patient. Results: Pretest: 37%
of the physician. CONCLUSIONS: The use of respi-
secretions appear warranted based on these
consistency, 46% accurate, 0% detrimental
ratory care protocols is an acceptable method of de-
preliminary demonstrating
data their safety,
therapy. Post-test: 91% consistency, 96%
veloping clinically effective and fiscally responsible
relative accuracy,and cost savmgs ($587 for PSB accuracy, 0% detrimental therapy.
care plans. RCPs at our hospital were able to imple-
versus $95 for mini-BAL). Conclusion: Single modality protocols can
ment care plans that resulted in cost savings without a
Prior value p valui overlook the optimal choice of therapy.
t ^
measured change in patient outcomes. Approval has
41) i-BAL Although RTs avoid harmful choices of
=
been extended from the Executive Committee of the
SaO, (%) 96.0±3,1 0.2568 modality, consistency in choosing the optimal
96.8jL3.2 medical staff to expand hospital-wide. [Respir Care I
Heart rate 99.6jLlO,8 I00.7±10.5 0.6425 994;39(7)7l5-724] modality is significantly improved with the use
of a multi-modality patient assessment protocol.
OF-94-052 OF-94-05
PULMONAHY REHABILITATION REFERRALS VALIDATION OF THE TRIAGE RATING Reductions in Oxygen and O.ximelry Hours
FROM A RESPIRATORY CARE SYSTEM with the ItnplementJtion of Patient Driven
ASSESSMENT/TREATMENT PROGRAM IN THE RESPIRATORY THERAPY CONSULT PnitcKols
JONI D. COLLE B5,RRT,RN
KEVIN L. SHRAKE MA, RRT
SERVICE Richard M Ford BS RRT, Jan E Phillips BS RRT .
protocols on 70% of our patient per axis for a maximum of 32 Triage Pomis, Tnage these sen kvs h.iscd <'n incdiLal si.ili.ippnncd
load. In addition to lowering costs Poinls are ordinalized into 5 Tnage Scores (1-5), guidelines. We e\.ilualed the impact PDPs had on
and improving communication, the where a Triage Score of 1 is assigned to patienis the hours of oxygen and oxymetry utilization and
assessment process has provided an with Ihe highest number of Triage Poinls (i.e , nio-ii the potential to reduce cost. Methods: Patients on
additional mechanism for pulmonary severe illness). Although we have found this raling the pulmonary tloor with request for oxygen
ehabi itati tha system useful over the past 2 years, validation of ihc and/or Continuous Oximeln,' were enixilled in the
improved quality outcomes. METHODS: system is not yel available, To ascertain whether prot(K-ol program RCPs pro\ jded an initial evalu-
Patient assessment sheets were Tnage Ralings correlate with clinical measures of ation to assess the appn>pnalencss ol therapy and
retrospectively audited for
patients' seventy of illness, the current research re-cvaluatn>ns e\ er\ 24 hours lu assess the lieed to
suggested referrals to our pulmonary
examines the association between the TRS (both continue sen leos io deieniiine it there was an\
Triage Poinls and Triage Scores) and clinical Ihc ..I the en
ncide ell I
measures of severily of illness in 98 palienl charge ivci'ids were nbtamed loi a d mnnlh pentKl
itor
RESULTS: Over a nine month period, receiving respiratory care at CCF Between 1/22/92 prior to llie PDP program iuid lor a 4 month penod
650 surgical and 100 medical and 7/14/93, Tnage Points and Scores were assigned after the prt>tocols had been phased in. The nunv
patients were evaluated for their to a convenience sample of 98 patients ordered to
ber of hours of oxygen and oximetry per patient
respiratory needs. Five new receive respiratory care As shown in Ihc table
were detemiined pre and post PDPs. For patients
referrals to pulmonary below, lor both Triage Points and Triage Scores,
in which owgeii or oximetry service was ordered,
rehabilitation were generated significant correlations (Spearman's rho) were
but iic\ci HiiiKikil as, result of the initial cvalua-
I
suit .ng four hom xyge observed with clinical measures, including length of
lioii lorapproprialciK-ss. a dcffcrrcd nx'ord was
EXPERIENCE: The RCPs slay, total hospital charges, charges for rcspiralory
was expanded beyond cask orientation mainlained. Results;
care acliviiics, and numbers of days receiving
to include enhanced patient respiratory care The number of deaths among
assessment skills. When patients did patients in this senes (N = 4) was too small to
not respond to titration from provide meaningful analysis of association with the
oxygen, further intervention was TRS
required from pulmonary
rehabilitation. Consults obtained
directly from the assessment process Wc conclude: I in Ihe current scrics. itic
'
TRS II.l IS
ratings currclaied signincanily with clii
resulted in identification of new
of patient acuiiy. and 2 although further study For oxygen, 1 2.8% of rxx^uest were delcrred and
home oxygen patients. In addition,
these patients were provided with needed, these data suggest that the TRS is a v.i
houn. of use per patient deci^eascd by 32.8% reduc-
instruction on breathing control and indicator of pnticnls' severity of illness ing total t)xygen houtN hv 1. 762. 1-'or oximetry,
1
self care techniques. I .S,()';; of reqiicsi wlil- d'efcnv.l and hour, of use
CONCLUSIONS: The presence of a [HT paiK-iii (kvuMsi\l I'\ M-i y [I'dik mi: oximetry
.
patient assessment/treatment program hours h> 7,')W (oiulusion krsulis iikiiuilc that
resulted in improved patient signifR-.inl raliKlmns uii Iv aJiu'val in oxygen
outcomes by identifying and reacting
aiuloMTncin houiMliioiigh pioUKi>ldiivctcd ther-
to home oxygen needs that were not
being addressed through traditional apy. W hilc no atKcisi- p.iiieni ris|>oiisc was
care plana. obsenetl. snbsi.uitial li>sI sa\ ings i.m Ik ahicvcd
as labor demand is redticed and Icwcr supplies
ctmsumed.
OF-94-099
r
A La Carte ?
^r-'5«^^
Or
One System On A Cart
The New ABL'" System 620
Blood Gases, Co-Oximetry, Electrolytes and Data Management
Near Patient, Complete Multi-Profiles For Stat Critical maintenance schedule will remind you when the limited
Care Analysis On Whole Blood maintenance is due. All without an external PC or separate data
Whether you prefer the mobility of a point-of management system.
Exhalation
Richard M
Ford BS RRT. MD
Jan E Phillips BSRRT David Bums . M MD Introduction; Protocol Driven therapy has been
UCSD Medical Cenler. San Diego CA. UCSD Medical Center since January,
inslituted at
1993. Wilh any new program, careful planning anil
Introduction: Patient Driven Protocols (PDPs) monuoring is essential lo success. The fiscal
allow the respiratory care practitioner (RCP) to ini- impact of protocol dnven therapy has been reported
tiate, modify, or discontinue therapy based on med- and has significant impact on the number and
ical staff approved guidelines, PDPs were intensity of therapies performed. We soughi lo
developed al UCSD to reduce the consumption of create amechanism to deternune if our protocols
department resources spent in providing care that would provide quality care lo our palienis. Method
was not medically necessary The protocols were We selected the high volume service of aerosolized
also structured to make therapy transitions to types bronchodilalor therapy. Monilonng for the success
of respiratory treatments demonstrated to be less of conversion from small volume nebulizer therapy
costly and could eventually be self administered by (SVN) to metered dose inhaler (MDI) device for drug
the patient. We evaluated the impact PDPs had in delivery was accomplished using an algorithm
facil L- ihei
incorporating infonnation from the physical exam.
Methods. The Bronchodilalor PDP incorporated
Daily evaluations were performed for each paiieni
the transition Irom hand held nebuli/er (HHN) to
with orders for bronchodilalor therapy. The
metered dose inhaler (MDI) when the patient
evaluation documents the physical exam, review of
demonstrated the physical and cognitive capabili-
[he lab data, chest xray results. PFT's, secretion
ties to use an MDI. The Secretion Clearance PDP
production, cough effectiveness and respiratory
incorporated the transition from postural drainage
and percussion PD&P) to autogenic drainage
I
hisiory. A plan for therapy is formulated utilizing
ihe algorithm, which provides a lemplale for
(AD) when the palieni uas physically able to per-
consistent decision making and goal oriented
fonn the required breathing patterns associated
therapy. The physician is contacted and the care plan
wilh AD and had a willingness to learn the
is finalized. Selected inrormaiion from tlie evaluaiion
technique Palienis wilh request for aerosol bron-
IS entered into a database managemeni system
chodilators and/or PD&P were enrolled in the pro-
tocol program RCPs provided an initial evaluation
to assess theappropnaleness of therapy and re- each 24 hour reevalualion From this database,
evaluations every 24 hours to assess the patients monitoring is performed for the following: 1)
PDP, 498 patients were initially evaluated. 38 conversion cntena as indicated on the protocol
were not started on bronchodilators as there was no algorithm. 3) Number of palienis who were
indication for therapy, 4 were able to start treat-
i 1
convened lo MDI. 4) Documentation of response lo
ment using MDIs rather than HHN, and 136 made MDI therapy, 5) Number of patients who were
MDIs during the coarse of their reslaned on SVN's. Results: A loial of 343 paiients
For the Secretion Clearance PDP. 439 were reviewed. Successful conversion to MDI
patients were initially evaluated. 120 were not therapy, as evidenced by improvement m PFT's or
started on chest physiotherapy as there was no indi- improvenient in breath sounds, was considered an
cation for therapy. 38 made the transition to AD outcome indicator For the year, the average
during the coarse of their treatment. Conclusions: success rate for successful conversion to MDI,
As well as identifying therapy request that may not utilizing the protocol algoriihm. was 98% (213
be medically necessary, PDPs can be structured to patients). Therapy failures occurred at a rate of 2%
facilitate transitions to less costly therapy. The re- (4 patients). Reversion to SVN therapy after
demonstrate substantial numbers of patients
sults conversion to MDI was considered a therapy failure
can make these transitions. The provision of these Conclusion; The rate of success for this protocol
alternative therapies at UCSD require less RCP prompted a change in depanmental policy which
time, fewer supplies, and provide another mecha- makes MDI the method of choice for all patients
nism to reduce department expenses. requiring bronchodilators, who meet the protocol
conversion crilend
OF-94-15
admmister or were mechanicalK ventilated We Target ranges iruluded an SpO^ of 90-92% for COj
procedure volume, cost and length of stay Our pulmonary. On seven pre-prolocol days (n=126 patients)
and sbi post-protocol days (n=105 patients), all patients
expanded substitution protocol included adults who with O2 ordered had an SpOj obtained. Concurrent records
requned assistance with MDl/spaccr. as well as of the post-protocol patients were also reviewed (466
neonatal and pediatric patients MD[/spaccr use patient-days) for protocol compliance. Results: An
mcreased to 87 9% of the 62.240 treatmeDls given by average of l.S Sp(32 measurements were done per patieni-
the respiratory care department from 1 1/93-3/94 day. CompUance for daily SpO^'s was 95%: 57% of
PA
,
MD .
MARK YOUR
(VenlMan u-as designed lor venulator palienis b\ oiu
I
iLOSvp' 4U days
ol adull
inlcrvcnlions by the Coordmator
We retrospectively
paUenis wilh ventilator
Tins subgroup ot -13
FUTURE AARC CONVENTIONS
length ol Slav
patients represented only 3 I % ot all ventilator patients m
FY92 but created a large economic burden and high
departmental workload RESULTS Thirteen non-
mandalcd interventions were identified and compiled
from most to least uulized Six most common
December 2-5, 1995
interventions were
lortim I
) structured and ongomg educational
lOO^^'ol. c g ,
I
scheduled inservices
prompting
for Residents, 2)
I )
December 6 - 9, 1997
New Orleans,
(
lino
1
was used as tie lung Kdel. Ite BVT linuui lung P was
used to record actual AP. Tie BVT coipliance was set at
B20 AP. Budson disposable tubing was used for tie CT.
Tie BV was placed 25 ci troi the wye on the inspiratory
.^
1
CA).Paramcleriusedonthe900C»ereViOSUII2..indIE 3 1
compliance (Cl) settings (0.2 and 0.4 L/cmH20i. PEF was detined as
maximum How during the exhaled breMh and RE was defined as
iPplat - PEEPtotaiyilow at onset of exhalation. For each \'alve and
condibon, 5 breaths were measured and the mean (SD) was calculat-
ed RESULTS:
(UcmmO
1
Measured
There comes a time when
all the valuable features become invaluable
BagEasy'"' Dispos^ible iM;uiu;il Resiiscitatoi's have away of becoming
essentid to tlie people who use tliem. Some say it's because tliey
can iLse PEEP witliout fii-st seaithing for a separate valve.
BagEasy's PEEP valve is built in. Otliers say it's because they
is sensibly placed up front, where you can see it. Still otliers
shape for an easy seal. BagEasy comes in adult, cliild, md infant sizes. Find out
what makes it invaluable to vou.
RESPIRONICS INC
The First Namk 1\ 1\\(i\ati\i-; Rkspiratory Care
COMPARISON Ol A W III A Ihl) WICK HU- M NEW SAFETY FEATURES INCORPORATED WITH
MIDII H M
H'\ S> Ml M lO 111 AriiDWIRH HEATED WIRE HUMIDIFIERS (HWH). SHINJI
AM) SI \\|>\Kl)\i\lll. MORflRfUITS FUKASAWA. BS. RCE. TETSUO M YAGSTOT
1
A TWO YEAR EXPERIENCE WITH FACTORS AFFECTING LATEX GLOVE Increased Expiratory Resistance
TEN DAY VENTILATOR CIRCUIT USAGE IN A BLOOD GAS LAB Due to the Normal use of a
(VC) CHANGE OUTS. James A. E)ebbie DiNicoia. Roben ChatbumJ^RT. Rain-
L.
Expiratory Filter- Ryan
Tyra, BS, RRT Jimmy W. , bow Babies & Children's Hospital, Cleveland. OH. Grueber,B HS,RRT University
Norwood, BA, RRT; The Hospital and Clinics. Columbia
University of South Alabama Universal precauuons mandate use of latex gloves
Missouri INTRODUCTION; Normal
Medical Center, Mobile, Al when handling blood samples. In our lab.use of use of expiratory filters on
INTRODUCTION Based on : powder filled gloves appai^nily led to more frequent mechanical ventilators may
available research studies we handwashing, dry irritaied skin, allergy lo powder,
extended our VC change out and higher glove usage compared lo powder free The STAR EXHALATION ISOLATION
interval from every 48 hours hypoallergenic gloves. Powder free gloves arc SYSTEM is regularly used on
to every 10 days. METHODS On : thicker, more durable and can be worn longer with ,
Servo 900C ventilators.
9/1/91 we began changing VC less irritation to the hards This study was to test ihe
HYPOTHESIS: Expiratory filters
every 10 days. Data for VC hypothesis ihai ihe higher cosi of powder free
increase expiratory resistance
cost and nosocomial pneumonia gloves would be offset by their lower rate of usage.
despite normal monitor ing of the
(NP) levels were collected METHODS: Normal usage of powdered gloves
ventilator and the patient.
for the study period 1990- (Kendall brand) and powder free (SafeSkin brand)
METHODS AND MATERIALS; A
1993. NP is defined as per was recorded for 10 days each. The number of
calibrated Servo 900C ventilator
institutional policy, various blood gas assays performed dimng the same period
with the STAR EXHALATION SYSTEM
combinations of clinical, was also recorded. Staff were blinded lo study
and an unmodified patient
radiographic & laboratory results but not glove brand because of obvious
circuit was attached to a
evidence of infection During .
differences between glove types, Average glove
mechanical model of the lung.
the study period there were usage (pairs/blood gas) was compared using a
The ventilator was then measured
no changes in ventilator for inspiratory and expiratory
non-paired l-tesl. Annual glove costs were
protocol. RESULTS For the :
calculated from mean glove usage and projected
resistance without the filter
year prior to 10 day changes blood gas volume, RESULTS: Glove usage {mean
system to get a base-line
S47580 was spent on VC with measurement. A set of filters
± SD) was less for SafeSkm than Kendall (p<0.001.
total NP levels of 120 or were marked and measured for a
see figure below). Skin condition (ie, presence of
10/month. In the 2 years bas The
redness, cracked cuticles and finger pads) appeared
since we have been doing 10 filters were then put on Servo
noticeably improved with SafeSkin. although this
day changes there have been a ventilators in use on patients.
observauon was highly subjective. At 8c/pair, the
total of 234 NP or an average The filters were taken off of
annual cost for Kendall gloves is estimated at
of 9.75/month. Ventilation the patients ventilators
$1,756 (assuming 50.000 blood gases/year). At
levels remained constant randomly from one to sixty seven
4 8«/pair. annual cost for SafeSkin is $5. 160
throughout. The average days and resistance was
CONCLUSIONS: WhUe the cost of the SafeSkin
length of stay on a remeasured. RESULTS: Thirty-
gloves is 500% more per pau- than Kendall, iheu-
ventilator in the ICN was nine filters were measured for
construction allows for longer wear, resulting in less
6.43 days, and for Adult expiratory resistance. The time
than 200% increase in annual glove costs, Ub staff on the ventilator was days to
patients was 4.78 days. In found that because the Safeskin gloves were thicker
1992 $30,865 was spent for 67 days. The least amount of
they could wash theu- hands with gloves on.
VC, and in 1993 $21,014. Our
contribudng to longer use. Improved skin condition
experience shows that 10 day by a filte was 0.85cm
and staff satisfaction might justify the increase in
change outs was a sound H20/L/sec. 'he greatest amount
cost.
economic and patient care e recorded was just
decision. CONCLUSION Our 2 :
under iH20/L/sec. The
year experience has shown a
total savings of $43280 while lidered to be
NP levels have remained
constant.lt is our conclusion r^TTq :
that change outs can be
safely extended to 10 days.
OF-94-057
THE EFFECT OF WEEKLY CIRCUIT CHANGES ON DEVELOPING A PROGRAM FOR Oxide Gas Sterilization on
EfTect of Ethylene
VENTILATOR-ASSOCIATED PNEUMONIA (VAP) MONITORING VENTILATOR-ASSOCIATED Accuracy of BICORE Transducers
RATE Dean Hess. MEd. RRT. Eduard Bums. RKT, NOSOCOMIAL INFECTIONS George Thomas J. Kallstrom.RRT. Roben L, Ch«tbum,RRT.
David Romagnoli. MS. RRT. Roben Kacmarek. PhD. M (^odhaii.. RRT. Craig Gilliam, BSCIC, Diane Moms.RRT. Rainbow Babies and Children's
RRT Departments of Respiratory Care and Anesthesia. Arkansas Children's Hospital, Little Rock, AR Hospital, Cleveland, OH
Massachusetts General Hospital and Harvard Medical iDtroductloD The purpose of
: this study was to evaluate
School. Boston, MA During an evaluation of heated-wire and describe the perfonnance of a new pneumotachomelci
Frequent changes of the ventilator circuit were once (Neonatal/Infant VarRex Row Transducer. BICORE) and
numidifier^ventilator circuits (HWC), we
thought to be important to prevent nosocomial pneumonia to detcimine the effect of repeated sierilizadon using
m mechanically ventilated patients There is increasing
sought approval to extend our ventilator circuit
ethylene oxide (EtO). This transducer is intended to be a
evidence that the frequency of ventilator circuit changes change interval from 48 hours to 7 days. Our
single use item. However, the manufactuier does stale that
Am presentation to Infection ControldCC) and ICU
does not affect nosocomial pneumonia rate (Dreyfuss.
it can be stcnlized once before use. Method: We
RevRespirDis 1991.143 738) The practice of frequent committees GCUC) emphasized an unproved evaluated 10 new flow transducers. Each was calibrated
circuit changes is costly m terms of both materials and closed system with reduced employee hand with the CP-100 Neonatal Pulmonary Monitor (Bicore)
personnel time We conducted this study to compare VAP contact- We received approval with the before making measurcmenis. A calibrated syringe (Hans
rates and cost reductions with 48 hr versus 7 day circuit condition that an appropriate monitoring Rudolph) set at a volume of 60 mL was used as the
changes METHODS The control group consisted of all
system would be developed without the expense standard. The syringe was pumped al a rale of 30 breaths
adult mechanically ventilated patients for the 6 month l)The number of per minute for approximately one minute. The inspiratory
of obtaining cultures:
period of 11/92-4/93, in which circuits were changed at 48 and expiratory volumes (averages of 10 txeadis) were
ventilator dayfVlCU/month was obtained from
hr intervals On 5/ 1 5/93. the circuit change frequency was recorded from die CP-100 display ATPD)- After
changed to a 7 day interval The study group then consisted
RCS 2)An Epidemiologist
shift report forms;
(al
1992-48 hr. tubing 1993-HWC probes was -3.9 lo 1.7 mL (inspiraiion. see Figure below).
patients} in the control group and 9 60 ventilator days 1
5.1 CVICU 2.8 Bias increased with sterilization and after the founh time
( 7 5 patients) in the study group The VAP rate for the
1
1
5.6 PICU 3.3 was -43 tnL. Imprecision (SD) increased dramatically
control group was 9 64^ 000 ventilator days SE 98. 95*4
1
rtoi change much
(
after the first sienliz^on but did
CI 7 7-1 6) and the VAP for the study group was 2.2 NICU 1.2
enor observed
1
OF-94-082
) 1 1
PERSONNEL COSTS ASSOCIATED WITH COSTS ASSOCIATED WITH DRUG COST SAVINGS AND AMORTI/ATKJN PKRIOD
UNIT-DOSE VS. MULTI-DOSE WASTAGE WHEN USING MULTI-DOSE WHEN CONVHR1 INt; FROM DISPOSABLH TO
MEDICATIONS rHEDICATIONS PHRMANENT OXIMETER SENSORS. John Newharl
RCP. David Bums MD, Corbeu Mask RRT MS. Richard
Brian M. Daniel RRT. RCP .
Ford RRT BS
MIchaal J. Mahlmelate r. MS. RRT. RCP
Michael J. Mahlmeister, MS, RRT, RCP
Brian M. Daniel, RRT, RCP U. or CaliforDia Medical Center Introduction: We are a 450 bed teaching hospiial. As
U. of California Medical Center Sao Francisco, California pan of a hospital wide Cost Competitive Swaiegy at
San Francisco. California UCSD. a 29% reduction in operating cost was established
lolroduction: Multiple contribute to
factors
as a target for Respiratory Care Pan of the cost reduction
Introduction: The cosi-elfectiveness of unil- determining the cosl-effcctiveness of unit-dose
(UD) versus multi-dosc (MD) bronchodilator
stragedy within RC included an analysis of maienal
dosG bronchodilaior medicalions (UD) versus resources consumed, particularly those ilems of high
medicalions. We evaluated the contribution of
multi-dose bonles (MO) is usually based upon a volume/high 92-93 disposable
the wastage factor of MD
use. by comparing
cost. In fiscal year
number of supply factors We studied the
the amount of MD
medication administered oximeter sensors cost S85.000 We evaluated the cosi of
contribution of personnel factors to the cost- with the amount of MD
medication purchased utilizing permanent sensors (PS) rather than disposable
effectiveness of UD versus MD. Methods: by Respiratory Care from Pharmacy over a six sensors (DS) Methods: Criteria for evaluation includes:
Twenty one RCPs parlicipated in the study, all month period. Methods: We conducted a The sensor would have to be applicable lo infant through
with previous experience using both UD and MD. retrospective count of all MD
bronchodilator adult All sensors would have to be reasonably easy to
Each RCP was timed prepanng a hand nebulizer treatments (albuterol solulion-Schenng) over a apply and stay attached to ambulatory palienls. The
treatment with a UD ampule (albuterolDey SIX month period Dau was compiled oximeters would have to correlaie closely with anenal
identifying the precise dosage administered blood gasses, have good ariifaci rejeciion. and function on
Laboratories), and a MD bottle (albulerol-
each treatment, so that a total volume of pauents with reduced penpheral perfusion. Sensors were
Schering) + an ampule of normal saline. All RCPs medication use could be calculated for this six lested for a one month period on ICU patients.
were instructed to prepare the treatment at month period. This medication consumption Approximately 30 palienls were u^ailed wiih both
their normal therapy pace, not to speed Each was compared to the volume of medication oximeters using DS and oximeters using PS Results:
RCP was timed twice for both UD and MD. and an purchased from Pharmacy for that same time hi a SIX montli period before conversion lo PS we spent
average was obtained for each technique period. Results: A total of 13,639 S35.838 on DS to administer 142.838 hrs of oximetry.
both small volume neb and large volu
Results: The average time to prepare the Subsiiiuiing PS would require a one time start up cost of
treatments were as follows: UD 13.95 seconds purchasing 70 permanent sensors with a 90 day warranty
albuier >l solution SIX month period.
(range 9.87 22 15). MD 32 68 seconds (range Total olume of r ion used for these
ai S75 each initially costing $5,250 This amount can be
an average 18,73 seconds longer than UD. thisequaled 28 days. In the six months since we convened
o( albuterol- At amounted tc
20ml/bottli :. this
to PS we administered 130.233 hours of oximiiry costing
Discussion: The additional time necessary to 513 bottles of medication consumed to
$ .250 The operational cost for PS dunng this time
1
prepare a MD treatment represents an added provide therapy. During this six month lime 1
$24.00/hour (salary + benefits) for an RCP. 33 PS desux)yed. and adhesives at S each x 7075 adhesive
Conclusions: A wastage factor of 779 bottles 1
18.73 seconds equals an additional cost of wraps used = $7,075 Conclusion: After the
can be calculated from the difference between
approximately 12 5 cents per MD treatment medication used versus medication purchased. amortization of the initial 70 PS. the cost of oximeu>
versus UD treatment Conclusions: Over a six At $3.26 per bottle, this represents a wastage went from $250/1000hrs for DS to $80/I000hrs for PS
month period, our staff administered 13,342 MD cost of S2.539 dollars, or approximately 18 for a decrease of 68%
treatments Using the figure of 12.5 cents/MD cents/MD treatment. A variety of factors are
treatment, added personnel costs for MD associated with the failure to consume a full
from 8/93-2/94 ( 2,500 patients ventilated for 12,356 humidifier and Hudson No. 161 3 Ventilator tubing set
wire circuits Vcnulalor circuits ot reservoir chambers
(Hudson RCI) with water traps (I5art No. 5275)) placed
days) Average duration ol ventilation for patients with were changed sooner if gross coniaimnauon with
in both tlie inspiratory and expiratory limb of the
VAP increa-sed from 6 2 to 6 7 days (p=0 19) Circmls sccrcuons and/or blood became apparent Policies
circuit WTien compared to the same time period ( 1
m the NlCt I/IMCI had previoush been changed Q
I
months) in the two previous years. VAP per 1000
regarding delivery hurmdity and icmpcraturc did
. ,
Monday Wednesday and J-ndav Adult circuits were not change over the swdy penod Also, VAP was
ventilatordays decreased in both RICUand MICU
standardly defined using insututional guidelines
changed Q48 hours Healed wire (HW) circuil« were (p<0.01 ) as shown below. Ihe number of ventilated
developed by our infection conuol department who
used pre and posl thangc in NiCU/I'ICU (TV<500 patients and duration of ventilator days did not change
assessed the results over the 24 month study penod
ml ) Non-llW circuits were inilialty used for alt other significantly. In 1993. using seven day circuit changes
Monlhly rates of VAPs were calculated per 100
patJcnLs but were replaced at 48 hours with HW circuits our costs for labor and supplies were reduced by
vcnulator-davs for 12 months before and 12 months
with the 7 day prokMx>l for paticni-s on prolonged (>48 $32,517 over previous years (048 hour circuit changes),
after implemenung the new policy and average rales
hours) ventilation suppbes decreased bv CONCLUSION: This study confirms that the
(, osl for
yvcre rrponed No significant differences in VAP
prolonged use of wick-type bumidifler with standird
t62.949iD7[Donth>(uuiualt/cdtuS107.9l3 with a rates before or affcr our policy change was noted
circuit does not increase the incidence of nosocomial
4 1 % de«;lmc m cncuils purcha.scd/ ventilator day) and pneumonia, even in high risk patienLs. lliese findings Overall, the average rate of VAP/pcr 100 vcnUlalor
labor costs decreased by S 1 5,825^caj We conclude suggest that proposed CIX' recommendations for days y^-as 40 for the 12 month penod before the
that Q7 day ventilator cucuil changes did not increase ventilator circuit changes ^ 48 hours can be extended to
policy change (range \9-i) b}). and the average
rale of VAP and rcniltcd in subsluilial nivings m 7 days using wick humidifiers and standard circuiLs, rate of VAP/pcr HX) vcnulalor days was S9 for the
nrppK'/labor costs with reduction m both VAP and cost. 12 month penod after the policy change (range 28-0 65)
We conclude ( I ) non-hcaied wire circuits on vcnula-
tors uulizing rouunc circuit changes oery 7 days was
not associaiod wnlh higher rates of VAP when com-
panng changes cyery' 72 hour^ (2) Annualized
to circuil
savings associated wilh weekly changes yvcre 57% ($17,911)
Our preliminary cxpcncnce docs not suggest a higher
frequency of VAP when changing vcnttlnlot tubing c\'cry
7 days but further data will emerge from this ongoing study
DOES A PROTECTIVE SHEATH ALLOWING REUSE THE EFFECT OF 7 DAY cmCUIT CHANGES ON
OF DISPOSABLE PULSE OXIMETER PROBES ALTER LX)WER RESPIRATORY TRACT INFECTION RATES IN
SENSITIVITY AND RESPONSE TIME? THE NICU AND Piru John W. Salver BS. RRT.
University
GB Russell. MD Department of Primary Children's Medical Center, and the
fl^ Gravbcal. CRTT
.
Utah
of Utah School of Medicine, Salt Lake City,
Anesthesia, PSU College of Medicine. Hershey. Pa. 17033
normal adult male volunteers were positioned supine and and recorded by the hospital's infection control
nurse
monitored continuously by a 5 lead EKG, RR and systemic A rate of LRI per ventilator day was computed for both
blood pressure. Two Nellcor D25 probes were applied, one
each to the Hrst and second digits of the subject's left hand.
Two Nellcor N200 oxuneters were used Respiratory gases
(carbon dioxide, inspired and expired oxygen, and nitrogen)
were measured by Raman Spectrometry (Rascal D. Ohmeda
Inc.. Louisville. CO, 80027). Each subject breathed a 90%
heUum 10% oxygen mixture to desaturate twice, with Fi02
:
MD. Ocpl of Rcspiraion Care. Thomas JcfTerson Univcr- CRTT,CPFT, Somen/ille Hospital, Somerville.
RRT, Dan Levin. MO.
Luis Toro-Figueroa, M D.,
MA
sn\ Uospilal. Phi/atielp/iia P.l
Children's Medical Center and
The University of
Texas Southwestern Medical Center, Dallas, Texas
liilrDducrion Since T-piece and trach collar Inals are often
75235
BACKGROUND The catastrophic effects of an
the final stq) in weaning a patient from mechanical untimely self or accidental extubation is well
venlilstion, il is of importance lo know standard values lor documented We are a small community hospital
WOB and Raw imposed due lo diHerent ETT and TTs INTRODUCTION; The incidence and types o( ETT
the and the multidiscipline ICU care team consisting of
Although this pnncipa! is the well known outcome of complications over a prolonged period of time m MDs. RNs. RRTs discovered dunng a TQM
documcntaiion ol
large pediatric populations are not well known. We
Pouisilles law. Uierc is surprisingly little
reviewed 15 years of experience in 16. 861 process that self-extubation had reached an
measured values m the literature Wc determined a
admissions, unacceptable level OBJECTFVE To reduce the
graphical set of standard values for WOB and Raw of
various [TIT and TTs over a range of mmuic vcnulations METHODS: Data were collected prosoectively on a number of self-extubalions METHOD
In study
daily basis by the PICU attending from Jan 1, 1977 **l, 59 were
patient's medical records
( Ve( Methods A bench study using a double test lung
setup to simulate a spontaneously brcathmg patient was to July 31, 1992, The data were tabulated and retrospectively received (afterTQM report) and a
performed to examine WOB
and Raw of size 6- 1 E ITs collected monthly. The tabulations were cntcna based policy/procedure was instituted to
and size 6 and 8 TTs over minute ventilations of 5-20 Ipm retrospectively reviewed. reduce the number of vanables (le restraints,
Ichanging both respiratorv rate and Vt and using peak flow RESULTS: 01 16, 861 admissions, 49% were sedation. air\vay management, alamts) between
to maintain an 1 E [alio of 1 2 with ihe Bear 5 vcnUlatorl medical and 51% surgical with an unselected patients In study #2 (after critena instituted),
The Adult Lung Function Anaiszer ALFA. Pulmonary ( mortality rate of 094. There were 7,106 initiations another retrospective study was performed with the
Technologies Industries, Ltd was used lo measure WOB ) of mechanical ventilation and 8,61 same basic results For study #3. the team decided
and Raw The data was then examined and graphed intubations. Of those. 2,520 were
to investigate, research and use commercialK
Results At a Ve of on]> 5 Ipm, the #6 ETT demon- 1,667 nasotracheal and 4,427 not specified. There produced tube holders on the market, as opposed to
strated a three fold mcrease m Raw over the HI 5 ETT and were 1.311 respiratory complications or 15% of all the old stand-by, adhesive tape or cloth trach ties,
a four fold mcrease over the «8 ETT At a Ve of 12 1pm. The r tiplic
thereby removing the last vanable TTie case team
ihc inspiraion cannal pressure necdmg to be generated m unplanned extubations 570 (43%), pneumothorax
deemed the Comfit trach tube holder supenor
the #8 ETT. Ihe 87 5 ETT, and the #7 ETT were -12cm 214 (16%), post extubation croup 200 (15%1,
il:0. -2t)cmJI:0. and -35cmHK5 respectively The «6 TT because heavy dut\', use ui all settings, reliable,
mucous plugging of tube 149 (11%), right
imposed twice the Raw of the «8 TT Graphically, the comfortable, ease of use. enhanced patient care,
bronchus intubation 39 (3%), other 139 (11%)
1*6I) TT proved to be identical lo a »7 5 FTT m WOB and stable and secure All patients in the study were
"Others* occurred less than a few times each and
include cardiorespiratory arrest, bleeding from ETT,
orally intubated according to protocol Our
infectious disease physician advises against
pneumomediastinum, subcutaneous emphysema,
aspiration pneumonia, bradycardia, teeth trauma,
nasotracheal intubations as the complications
pneumopericardium, tracheostomy decannulation, outweigh the advantages RESULTS Given a
tube malposition, nose bleed, left mainstem national average of approximatelv 10% our studies
bronchus intubation, kinked tube Of the unplanned found Study* I sclf-extubation-15% (9/59) Studv
extubations the cause was stated for 59 (10.5%) Ml Selfext{ibation-9% (6/34) Study «3 No self
and included seif-exiuoaiion 14 (25.7%i; during CPT extubations-0% (0/24) after existing policy of using
12 (20.3%). X-ray 7 (11.9%), weighing 5 (8 5%), the Comfit with the cntena in Study U2
retapmg 4 (1.6%) moving patient 3 (5,1%), aerosol CONCLUSION Endo tubes have been a part of
therapy 2 (3.4%), bathing 1(1.7%), stanmg IV 1 intensive care medicine since the late 19th centur>
{1,7%1; or secondary to coughing 6 (10.2%), Accidental extubations are statistically relevant and
secretions 2 (3 4%), or maternal factors 2 (3 4%). with enough senous complications to warrant
CONCLUSIONS: The incidence o( complications of constant vigilance Our cxpenence along with
intubation is relatively high (15%), with unplanned others, that heightened awareness (Hawthorne
Conclusions There are dramatic dilTerences m Ihe WOB extubation (43%) being the most common of these and
effect), patient, family, staff inservice, sedation
and Raw imposed bv the various sizes of endotracheal tubes Of unplanned extubation, the most common causes restraints are key ingredients inreducmg unplanned
which musi be considered wiien inmbaling a patient There are patient self extubation; during CPT. X-ray. and extubations Unfortunately, not enough attention
IS a dramatic dilTerencc m WOB of vanous tracheostomy weighing; and secondary to coughing. has been paid to the actual tube and its secunng
tubes, which is especially important for trachcostomv
device Our experience has been and continues to be
paiienis who are dilTicuii to wean with limited reserve to
WOB and Raw We have initialed a -the proper ENDO TUBE PROTECTOR (ETP),
overcome the imposed
the Comfit, the incidence of self- extubations
study to compare Ihcse bench results lo those in the climcal
decrease significantly
setting to assess tube patcnev
OF-94-242
OF-94-091
TRACHEOSTOMY CURRENT IN THE 1990's INSPIRATORY WORK OF BREATHING AIRWAY RESISTANCE TIIROUCn
CLINICAL PRACTICE IN AN URBAN TEACHING IMPOSED BY THE ENDOTRACHEAL TUBE NEONATAL A PEDIATRIC
HOSPFTAL CL Kasoer RRT. CR Stubbs RRT, JA Barton, AND VENTILATOR DEMAND VALVE DURING ENDOTRACHEAL TUBES
KS Hazel MS. JR Hedges MS, DJ Picrson MD, Harborview PRESSURE SUPPORT & T- PIECE WEANING .
m hospitals, done for multiple reasons, by several services, V^irae Hill BSc RRT Military College o( Health
MD. Duke Universilj Medicnl Center,
with pts located throughout the hospital in Ihe absence of a Sciences. DHAHRAN Chnslopher C Miller BA RRT
Durham, NC
defmed institution wide procedure for assessment, and wilh David Dyer BSc RRT. Vicki Foulkrod BA RRT.RCPT &
no recenl literature to descnbc current trach management, Mahmoud Barbara MD King Faisal Specialist
Et Increased work or hreathinft (WOB) can
wc conducted Ihis retrospective study Malenals and Meth-
Hospital and Research Center RIYADH, prolnng the need For renlilalnry .support.
ods Harborview Medical Center is a university operated
Kingdom Saudi Arabia
of Airway resi.slance (Raw) is altered hy
murucipal hospital, and level trauma center, with 320
I
INTRODUCTION The Pressure Supporl (PS) weaning endotracheal tuhe (Ell ) sir* and in.'jpiratory
beds ( 38 ICU. 87 acute care, and 26 rehab) Trach pts arc
dispersed throughout
1
performed on what population'' 2) Who performed/managed overcomes Ihe resistive load imposed by the ETT
determine the relnlinaship, we examined (he
the Irachs"* 3) What post care was given, especially by and the Siemens 900C venlilalor this ossurnplion If
Rnw or neonnlnl ond pedialric ETT's a(
RCP's'' 16.491 pis were admitted m the fiscal year 1992- IS valid we should be able to safely exiubate Irom this
varying Dow mles u^ing a bench model.
93, ofwhom 20 were identified as havmg a trach Wc
1
level of ventilatory support which simulates the work of
reviewed the records of 109 pts, (3 were unobtamablc and 8 breathing (WOB) post eidubation
METHODS: ETT si7c 2.0 - 5.5 were sdidied.
were miscoded) These records compnscd 147 admits Re- METHOD: We prospectively studied (9) post Flow ra(cs were vnrird from 3 - 25 LPM
sults0{ Ihc 09 pts. 74% were male and 26% were female
1 operative, cardiac surgical patienis wilh no pre-existing (hrough each (iihe. The Calihra(ion Annly/fr,
Age ranged from 13 lo 83 (mean±SD = 44 5±19 8) 11% lung disease on the day of extubation We measured Scries RT-200 fTimeler Ia';(rumenL<; Corp.
died, 29% were discharged lo home, 39% to subacute care WOBp (patent) using Ihe BiCore CP-100 Pulmonary Lnnca.';(er,PA) was used In measure Raw in
ccnlCTS. 12% to another hospital. 5% to nursing homes, Monitor dunng six stages of PS weanmg, T-Piece cm ll20/L/sec. Three mea.surcmenLs were made
and 5% to other inslituuons Pt dx mcludcd trauma 43%, weaning and alter exiubalion using a mouthpiece (MP) a( each seKinf; and averaced. The calihra(ion
CVA 12%. pncumoma 10% CA 7% and other 26% Pts .
+/or Facemask(FM) connected to Die (low transducer
nnaty7£r was /rroed prior lo each chnnge.
underwent trach for ihc following reasons 21% prolonged Nomial Range WOB= 3-0 6 J/L
20% closed 5% spmal cord inju- RESULTS: Rnw increai^es wi(h decreases in
ventilation. head injuries,
RESULTS: WOB J/L) vs Weaning Condition(
ncs. 22% facial injunes. 3% epiglotitis, 6% other H&N PSMax PS15 PS10 PS5 PSO PSO TP
ETT sire and incren-ses in (low ra(es. See
surgery, 1 6% other intracranial bleeds and 8% other Ad- CPAP 5 5 5 5
(trnph.
mitting services were Gen Surg 29%. Medicine 25%, Ncu-
Mean 0.03 04 13 0,39 0.66 91 67
rojurg 20%. Ncuro 11%. OTO/HNS 5%. Rehab 5% and
other WTviccs 3% Length of stay ranged from to 1 36
SO 0.04 0,07 0,12 0.26 17 0,29 0,19
In all patients, WOBp increased above
I
J/L when
days, (mcanlSD 32 4t30 4, median 24) 63% were Inched
PS was reduced below 5 cm H O & CPAP 5 cm H -O
that admiisionThe procedure was almost always done in
the operating room Services pcrformmg were Cicn Surg
and decreased after exiubalion The gf eatest WOBp
was seen whenboth PS and CPAP were reduced to
(17%), oro/FIN (29%). Neurosurg(14%). OMFS (1%).
Bums Plastics (2%) 47% of those trached were ventilated 0cm H.Op^ 0005 The WOBp at PS 5 cm H;0.
on admission, 63% were ventilated ut some pomt m thcu
CPAP 5 cm HjO was wiihin the normal range of WOBp
hospital iitav. 38% were never on ventilator Of the pt.i wilh (p > 10) There was no diMerence in WOBp between
trochs 2/3 had orders and 85% had progress notes pertain-
T-Piece&PSO, CPAPScmH.O p>0 10 The CP-100
ing to trach marugcmcnl In 36% another service vnu con- monitor displayed post extubation WOB as WOBv
sulted for trach management 100/147 admissions hod RT (ventilator) 07 /-0 01 J/L when the MP wos used
fii<l one on days post trach
notes regarding trach. the When the same measurements were taken using FM
(mcanlSI) 1 2l5 5) 81/147 had notes pertaining to cuff (in 2 jf 9 cases the CP-100 displayed WOBp
) . 58 &
volume K8/M7 had notes rego/dinit cufT pressure C^ oflclu - 86 J/L respectively
UOO Wc determined that many difrcrcnt servicc!i, locations CONCLUSION: The PS level of 5 cm H.O & CPAP
and dx ore involved in pts with trochs We conclude there m of 5 cm H;0 most closely matched the normal range of
a need for access to all Iroch pu by multidisciplinary exper- WOBp +/- 33% The results in this group of patienis
( )
COMPARATIVE EVALUATION OF
ENDOTRACHEAL TUBE RESISTANCE IN
RECENTLY EXTUBATED INFANTS AND
CHILDREN
ETT
o T-shirt
Rich, jewel-tone colors of forest green, purple, and
gold display your professional pride on a 50/50
cotton/polyester blend T-shirt. Medium, large, extra
large, and extra-extra large available.
©Sweatshirt
Don't wait to order this classic RC Week
sweatshirt in fashionable forest green. Sweatshirts
are 50/50 blend. Medium, large, extra large, and
extra-extra large available.
@RCP Cap
Add the finishing touch to your RC Week
apparel with this forest green cap, silk-
screened in metallic gold.
IN VrfRO DATA
CVraic n |N0] Test Lung [NO|FT
INVTVODATA
1
SI i n I
\in, Johmu
r, rXirham. NC
hxlnicdqxircal Membrane (H>pcnalnin (ECMdl
cl> used Ki licut rmnulL-s uith uifili<>a-<ipir3Uir>
It
the I.K with a line da> hislur> ol hack & abduminal pain He influence the accuracy of measurements Methods We used a
Ma> jdmilU-d Mith a Sp02 '~>' i>n luum ait and a W^ Puritan Bennett 7200 (Punlan Bennett Carlsbad CA i
hemoglobin o( f> d gm dl I'hj-.ital c\am revoaled moderate ventilator with "Pressure Cycled Ventilation'' sofiware The
respiratno distress with a rcspirat(«> raic of 49, pulse of ventilator was connected to a rubber lest lung via a standard
130. BP of 1 10 fiO and a Icmpctalurc of ^9 1 degrees disposable circuit devoid of a humidifier SOOppm source NO
centigrade Initial C'\R revealed iioair space disease The gas was mixed via a special stainless steel Bird Blender (SSD)
patient was treated wilh supplemental o\>gen\ia nasal (Bird Corporation Palm Springs CA ) wiih Pure Nitrogen
cannula at 2 1 I'M 2-4 hmirs later ;i repeat <'\R re»eakd
LLL itiTilUatc & cltusion Ik «as iranslerred to Diike ventilator The oxygen inlet of the ventilator was connected
liuver^il> Mcduaii enlerlof lunhcrliealmem Wotkupal oxygen. Gas exiling the ventilator was
to cUnical NO-N2-02
DL MC: mcliukd a (
' \ 1 scan w hith re. caled consi.lidation
as set by the ventilator oxygen control and the external SSB
of the left lung, increased opacii\ in the nghl lower lobe and
dial Thus oxygen and NO concentrations can be manipulated
pnihable ikcIuskhi of the left main stem bfimchus The
The No analyzers an API 200 (Advanced Pollution
paUent was intubated appioxiinatel} I7 hour> aUcr
Instrumentation San Diego CA CL type and a Micro Medical
admi«ion to !)l MC
for mechanical * entilation and to
t
lungs The patient was deemed to have a greater than 9(yi min. and 22% oxygen Al each setting change the system wa
chance ol monalit> Uronchi.tscopic removal of secretions allowed to equilibrate fur two minutes. A mean was derived
was not piMsible due to hemtxixnamic instabilil) and \'cno with both devices at each IE
by collecting readings
setting
Artenal f:CMO .las initiated I he patient was suppt'>ncd over one minute Results The following table shows the
withhCM()at lluMsni llKml kg min panided by a ft"
mean readings of each device at each IE ratio, with a
roller nnga
Therapcuuc hronthoscopy was perl ormed twice a da> whili
K!M() was maintained witheMcnsive mucous pluj
support
l:E RATIO 1:3 II
removed dunng each bmnchoscop) The patient shnwed
remarkable improvement bilateral clearing of the C\R &
over U»c bCMO
course LC'MO was discontinued after 106
ECmean 34 7 35 1
treated with RCMO with a loial survival rateof 26T We as compared 1:3 V as 0. (
report the Hrst pedia ordinal regression values for (he successiv
bC\' ofLt levels for Tirm signiricantly increa
aggressive and luxurious bro[Khi>s4.op\ s for NO P< 0001
Conclusion Each instrum
at
obstniction. ECMO should he considcrc similar pattem of increasing values on each IE le
theiap) in patterns with refractory airwa; ugh the mean values for successive levels of IE r
brought on h> severe mucous plugging atistacaUy signincant it remains
s clinically signiHcani
Pediatrics Loma Linda University Medical Center and ventilation (CV). However, many infants who fail CV
Loma undergo a trial of high frequency oscillatory ventilation
Loma Linda University School of Medicine.
(HFOV) prior to ECLS Unfortunately, Oierc arc no
Linda, CA accepted guidelioiis'to indicate HI=OV failure Wc.
With the increasing use of high frequency therefore, evaluated critena for the use of ECLS in
oscillatory ventilators (HFOV). clinicians have begun neonates treated with HFOV (SensorMedics 3100A)
delivering aerosolized medications through HFOV usmg a high volume strategy Ventdaior and blood gas
circuitry We asked whether the location of the aerosol daU on all potenUal nonsurgical ECLS neonates
treated with HFOV
between 1/92 and 5^4 were
generator in HFOV circuits would affect the volume of
retrospccdvely gathered from a
aerosol delivered to the end of the endotracheal tube Wc
(Ol)
aerosolized a 41 mot phosphorus solution through a (P(a/A)02). were
ygen tension ratio
commercially available aerosol generator (AG) (Hudson calculated Additionally, a ventilation oxygenation
« 1 790. mass median diameter 5 1 \xm) placed into a index (PaCOj x OI=VOI) was developed to include data
HFOV (ScnsorMedics 3100) circuit The baseline on the efficiency of ventilation. Criteria for institution
ventilator senings were; frequency 10 Hz, amplitude 25 of ECLS in Uicsc patients was highly variable and based
cm HjO. mean airway pressure 15 cm H^O. inspiratory' solely on an individual practitioner's impression ihot
HFOV had failed. The Ol. P(a/A)02. and VOI. were not
lime 33%. and circuit bias flow rate 15 L/m We
calculated prospectively to aid in patient management
positioned the AG's in the inspiratory limb of the
decisions Seventy-four outbom neonates were
ventilator circuit at three different locations: immediately evaluated 40 MAS/PPHN. 26 sepsis, and 8 with oOier
distal to the humidifier (62 cm proximal to the patient diagnoses. Forty-one neonates (55%) responded (R) to
wye), 10 cm proximal to the patient wye. and between HFOV avoiding ECLS (68% MAS. 35% sepsis, 63%
the patient wye and the endotracheal tube We collected other) while 33 (45%) did not respond (NR) requiring
the aerosol sample on a glass filter paper ((ielman) ECLS Seven (5 septic. 2 MAS) of the NR required
emergent cumulation making data acquisition
located in line between the end of" an endotracheal lube
impossible These patients were excluded from further
(3 5. length 15 cm) and an artificial lung (compliance I
placed it in 10 ml of deionizcd water to resuspend the (table). Eighty-seven percent of the patients with an
phosphorus, I wo samples of the resuspendcd phosphorus Ol>60 required ECLS. while only 29% of those widi an
solution were analyzed in duplicate by a OI<60 required ECUS In the latter puUcnts, ECLS was
instituted due lo pcrsistint air leak or cardiac arrest.
spcctruphomeiric iiiclhoiJ Five aerosol izat ion were dune
There were no deaths ui the R group and 6 deaths in the
ateach location with five AG's (25 studies for each
NR group Within die NR group die uiitial and highest
location) Wc calculated the percent of phosphorus mean Ol in nonsurvivors was significantly greater dian
delivered and analyzed the difference between the A(i the lorvivors (36 3 vs 98 5. p=005) Wc conclude: 1)
locations by I -way ANOVA Ol. P(a/A>02 and vol ire all capable of predicting ECLS
Fhc mean amount of phophorus delivered to the filter requirement in HFOV patients often within the first
paper was between I and 5% for hour of HFOV 2) A retrospectively calculated high
mean Ol > 60 waj wsociUcd widi an 86% requirement
Ihc three AG locations. The mean
for ECLS, 3) The fact that 6 desthi occured in Oiia
amount of phosphorus delivered ti
Ol was highest in the non-survivors
scrict and that die
the niter paper increased as the would suggest that delayed initiaUon of ECLS may
distance between the AG and the contribute to morbidity and mortality 4) Based on the
wye decreased, however, pnoT con
m
patient 3
EARLY VERSUS
1
EXHIBITORS
at the 40th Annual Meeting and Exposition of the
American Association for Respiratory Care
Exhibit Hours
CONVENTION EXHIBITORS
CONVENTION EXHIBITORS
M O
Maginnis and Associates 847 Ohmeda 719
Mallinckrodt Medical, Inc 1037 Omni-Tech Medical. Inc 1347
Marquest Medical Products. Inc 608, 610, 612, 614 Omron Healthcare. Inc 1342
Marquette Electronics 1149 & 1151 Ottawa University Kansas City 510
Martell Medical Products, Inc 622 & 624 Oxigraf. Inc 946
MBNA Marketing Systems, Inc 250
Medical Data Electronics 512 & 514 P
Medical Graphics Corporation 1 129
Medical Plastics Laboratory, Inc 449 RK. Morgan Instruments. Inc 1018 & 1020
Medical Taping Systems, Inc 1249 Palco Laboratories 945
MEDIQ/PRN Life Pall Biomedical Products Company 711. 713. 715
Support Services, Inc 525 & 527 PARI Respiratory Equipment. Inc 342
MediServe Information Systems, Inc 1019 Passy-Muir. Inc 1 146
Medisonic USA, Inc 230 Peace Medical. Inc 226 & 228
MedRehab Incoiporated 1411 Pegasus Research Corporation 202
Mercury Medical 236 & 238 PeiTy Baromedical Corporation 1 145 & 1 147
MES, Inc 206 PHI Enterprises, Inc 243
Michigan Instruments, Inc 747 & 749 Phoenix Diagnostics. Inc 1412
Micro Medical Limited 101 PPG Biomedical-Sensors 931 & 933
MMCA/Misty Ox 433 Precision Medical. Inc 949
Monaghan Medical Corporation 813 Presbyterian Hospitals of New Mexico 347
Mosby 214 Primedica 211
MSA 504, 506, 508 Pro-Tech Services 1421
MultiSPIRO, Inc 1423 Professional Medical Products, Inc 810 & 812
CONVENTION EXHIBITORS
The American Association for Respiratory Care and its sci- Abstract Format and Typing Instructions
ence journal. Respiratory Care, invite submission of brief
abstracts related to any aspect of cardiorespiratory care. The Accepted abstracts will be photographed. First line of abstract
abstracts will be reviewed, and selected authors will be invit- should be the title in all capital letters. Title should explain
ed to present papers at the OPEN FORUM during the AARC content. Follow title with names of all authors (including cre-
Annual Meeting in Oriando. Florida, December 2-5, 1995. dentials), in.stiaitions(s), and location. Underline presenter's
Accepted abstracts will be published in the November 1995 name. Type or electronically print the abstract single spaced
issue of Respiratory Care. Membership in the AARC is in the space provided on the abstract blank. Insert only one
not necessary for participation. letter space between sentences. Text submission on diskette is
ously in a national journal. The abstract will be the only evi- time it is used. Any recurring phrase or expression my be ab-
dence by which the reviewers can decide whether the author breviated if it is first explained. Check the abstract for (1) er-
should be invited to present a paper at the OPEN FORUM. rors in spelling, grammar, facts, and figures; (2) clarity of lan-
Therefore, the abstract must provide all important data, find- guage; and (3) conformance to these specifications. An ab-
ings, and conclusions. Give specific information. Do not stract not may not be reviewed.
prepared as requested
write such general statements as "Results will be presented'" Questions about abstract preparation may be telephoned to
or "Significance will be discussed." the editorial staff of Respiratory Care at (214) 243-2272.
An original study abstract must include ( 1 ) Introduction: Authors may choose to submit abstracts early. Abstracts re-
statement of research problem, question, or hypothesis; (2) ceived by March 1 5 will be reviewed and the authors notified
Method: description of research design and conduct in suffi- by April 22. Rejected abstracts will be accompanied by a
cient detail to permit judgment of validity; (3) Results: state- written critique that should in many cases enable authors to
ment of research findings with quantitative data and statisti- revise their abstracts and resubmit them by the fmal deadline
cal analysis; (4) Conclusions: interpretation of the meaning (May 27).
of the results. A method/device evaluation abstract must
include ( 1 ) Introduction: identification of the method or de- Final Deadline
vice and its intended function; (2) Method: description of
the evaluation in sufficient detail to permit judgment of its The mandatory Final Deadline is May 27 (postmark).
objectivity and validity; (3) Results: findings of the evalua- Authors will be notified of acceptance or rejection by letter
tion; (4) Hxperience: summary of the author's practical ex- only — to be inailed by August 15.
rectangle shown.
Respiratory Care
Open Forum
11030 Abies Lane
Dallas TX 75229-4593
Early deadline is
Final deadline is
Not-for-profil organizations are offered a free advertisement of up to eight lines to appear, on a space-available basis, in Calendar of Events in
Calendar RE,SP!RAT0RY Care. Ads for other meetings are priced at $5.50 per line and require an insertion order. Deadline is the 20th of the month two
months preceding the month in which you wish the ad to run. Submit copy and insertion orders to Calendar of Events. RESPIRATORY CARE.
of Events 1 1030 Abies Lane, Dallas TX 75229-4593.
AARC & AFFILIATES sents Its annual meetmj: Call (301 ) 897-5700 for infor-
mation.
December 9 in Las Vegas. Nevada. The AARC and its
Board of Medical Advisors present a postgraduate course November 18-22 in Atlanta, Georgia. The Gerontolog-
for medical directors and other physicians the day before ical Society of America presents its annual meeting. Call
the Annual Meeting, The program is approved for 6
(202) 842-1275 for information.
Category I credit hours of the Physician's Recognition
Award of the American Medical Association, Lecture
November 30-December 1 in Washington, District of
topics include ethical dilemmas in the ICU. TB as an
Columbia. The Bureau of Health Professions. Depart-
occupational hazard, cost-effective management of criti-
ment of Health and Human Services, hosts its national
cal illness, and all aspects of providing respiratory care by
conference, "Multiskilling and the Allied Health Work-
protocol. Contact the AARC at (214) 243-2272 or fax
force," at the Key Bridge Marriott, Featured topics
(214) 484-2720 to request that a complete course descrip-
include education and training models; multiskilling and
tion and registration form be sent to your medical director
patient-centered care systems; restrictions to practice;
or other interested physician,
competency assessments; and state initiatives and strate-
December 10-13 in Las Vegas, Nevada. The AARC pre- gies. Registrants receive the white papers written on con-
sents its 40th Annual Convention and Exhibition, "A New ference topics in a pre-conference mailing. For a
Vision," at the Las Vegas Convention Center. For infomia- conference brochure and registration form, fax your
tion, contact the AARC at (214) 243-2272, fax (214) 484- name and address to Lana Phillips, Continuing Education
2720. Coordinator, Allied Health Education Center, Methodist
Hospital, Indianapolis IN, at (3 1 7 929-2 02 or call her at
) 1
February 14-17, 1995 in Reno, Nevada. The NSRC and (317) 929-8925 with questions about registration and
the American Lung Association of Nevada present the 14th hotel reservations. For information on speakers and the
Annual High Sierra Critical Care Conference at the Pepper- program, contact Sherry Makely at (317) 929-3282 or fax
mill Hotel/Casino. The 4-day conference covers critical care (317)929-2102,
topics in adult, pediatric, and neonatal medicine. Contact
Colleen Banghart, American Lung Association of Nevada, February 5-8, 1995 in Breckenridge, Colorado. The
PO Box 7056, Reno NV 89510, American College of Chest Physicians sponsors "Cardio-
pulmonary Wellness and Rehabilitation" at The Village
March 12-15, 1995 in Denver, Colorado. The AARC atBreckenridge Resort, Contact Arlene Karavich,
and the National Jewish Center for Immunology and
American College of Chest Physicians, 3300 Dundee Rd.
Respiratory Medicine announce the call for abstracts for
Northbrook IL 60062-2348, (708) 498-1400,
the 5th International Conference on Pulmonary Rehabil-
itation and Home Ventilation at the Hyatt Regency Hotel,
April 1-7, 1995 in Miami, Florida. The Ventilation
The abstract deadline for poster/oral presentations on
original research/clinical observations is Nov 30, 1994,
Assisted Children's Center (VACC) of the Division of
ment, and transtracheal oxygen. The program is endorsed swimming, field trips, structured games, and campsite
by the American College of Chest Physicians; program entertainment. The campsite, the Leisure Access
chairman is Barry Make MD, Contact the National Center at metro Dade county's AD Barnes Park, is a
Jewish Office of Professional FAlucatit)n at (303) 398- handicapped-accessible urban park located 2 miles
1000, from the hospital. Medical staff and equipment are
available 24 hours-a-day. Contact Cathy Klein,
OTHER MEETINGS VACC Program Coordinator, Division of Pediatric
Pulmonology, Miami Children's Hospital, Suite 203,
November 18-21 in New Orleans, Louisiana. The 3200 SW 60 Court, Miami FL 33 155-4076, (305) 662-
American .Speech-Langiiagc-Hearing Association pre- VACC,
Advertisers
in This Issue
Allen & Hanburys 1031, 1032, 1033 Lifecare 1087
Automatic Liquid 1079 Medical Graphics 1089
Baxter Healthcare Coip 1069 Mercury Medical 1030
Bear Medical Systems 1081 Michigan Instruments 1026
Ceramatec 1020 Monaghan Medical 1074, 1075
Chad Therapeutics 1071 Nellcor 1025, 1066
CNS 1023 Newport Medical 1091
DHD Diemolding Healthcare Div 1018, 1077 Nonin Medical 1093
Driiger Critical Care Cover 3 Passy Muir Cover 2
Fisher & Paykel 1029 Pedipress Inc 1034
HealthScan Products Inc 1036, 1037 Puritan-Bennett Corp 1095
HR Incorporated 1028 Radiometer America 1097
Impact Instrumentation 1065 Respironics 1024, 1105
Int'rasonics 1035 Sechrist Industries 1098
J B Lippincott 1033 Sherwood Medical Cover 4
Interchangeable Reservoirs
116 Ceramatec
Oxygen Analyzer
117 Chad Therapeutics
Portable Oxygen
118 CNS
CIMSSIeepLablOOOP
94 DHD
Incentive Spirometer
111 DHD
MDI Spacer
101 Drager
Ventilator
120 Infrasonics
Star Ventilator
126 JB Lippincott
Books
150 Liiecare
PLV-100
141 Medical Graphics
Prevent Pneumotach
95 Mercury Medical
CPR Bag
121 Michigan Instruments
PneuView Testing & Training
Systems
122 Monaghan Medical
Peak Flow Meter
123 Nellcor
Sensors
148 Nellcor
UltraCap Monitor
139 Respironics
Recruitment
Use these
BUSINESS REPLY MAIL
FIRST-CLASS MAIL PERMIT NO. 604 RIVERTON, NJ cards to
POSTAGE WILL BE PAID BY ADDRESSEE
AARC PUBLICATIONS
POBOX 1856
RIVERTON NJ 08077-9456
I.mI..I.II...I...II...II.I...I..I.I.I..II...I..II
NO POSTAGE
NECESSARY
IF MAILED
IN
UNITED STATES
THE sue.
AARC PUBLICATIONS
POBOX 1856
RIVERTON NJ 08077-9456
l...l,.l.ll...l...ll...ll.l...l..l.l.l..ll...l..ll
Return Address
Place
Stamp
Here
lln,l.l,l,..l.lnMI,l<..l..l.l.l,l.l,.Mll..l..ll
CPAP Always
A Step Ahead!
Evita makes work of breathing
even easier!
0.5 t(s)
patients.
ventilatory drive.
1 2
With Drager you can stay one step ahead in
choose...
Drager
Technology for life
Las Vegas
-^
RESPIRADYNE^n
•* [PLUS
PULMONARY FUNCTION/VENTILATION MONITOR
'''
^aphic Printouts... Multi-Patient Memory.. .and Easy to Use
Results-Oriented Features At Cost Effective Prices
New Graphic Forced Vital Capacity (FVC) document printout of Flow vs Volume and
Volume vs Time New 10 patient memory with 8 pre-bronchodilator and 8 post-
bronchodilator tests per patient and automatic calculation of % change New customizing
software package New Slow Vital Capacity (SVC) monitoring Automatic determination
of "best test" Knudson, ITS and ECCS reference nomograms Easy to operate
For further information, call: 1-800-325-7472 (outside Missouri) 1-800-392-73 18 (in Missouri)
ik Sheriuood
^^ MEDICBL